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Malaria remains a significant public health problem worldwide, and especially in the 
Democratic Republic of the Congo (DRC), where approximately 12% of global cases occur. 
Despite this burden, very few national malaria studies have been conducted in the DRC, 
particularly amongst adults. Because of this, critical questions, such who is at highest risk and 
where transmission is highest, remain under-studied. This information is needed to tailor 
interventions to individuals and areas in which they will be most effective. We aimed to fill this 
gap in the literature using data from the population based, nationally-representative Demographic 
and Health Surveys (DHS) conducted in the DRC.  
Using DHS data, we evaluated the status of malaria prevalence amongst adults in the 
DRC, and determine changes in prevalence over time. We found that the national prevalence is 
high, approximately 30%, and that the prevalence of patent infections increased from 2.4% in 
2007 to 7.5% in 2013. We identified several risk factors for infection, such as traditional housing 
and decreased within-household net coverage. However, we also found that while uptake of 
malaria interventions has increased since 2007, use of long-lasting insecticide treated nets 
(LLIN) and intermittent preventative therapy during pregnancy both remain low. Increasing 
LLIN use was associated with only a small reduction in prevalence of patent infection, pointing 
to the need to re-evaluate current malaria control strategies.  
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Overall, this dissertation highlights the high prevalence of infections amongst adults and 
the need for massively scaled up malaria control efforts. The findings identify individuals and 
areas that most need attention. These findings will help the DRC Ministry of Health plan future 
malaria control programs and help ensure that such programs are maximally effective. This 
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CHAPTER ONE: SPECIFIC AIMS: 
Malaria remains a significant public health problem in the Democratic Republic of the Congo 
(DRC), with an estimated 25 million cases in 20181. Despite this burden, there have been very 
few national malaria studies conducted in the DRC, particularly amongst adults. Because of this, 
critical questions, such as who is at highest risk and where transmission is highest, remain under-
studied. This information is needed to tailor interventions to individuals and areas in which they 
will be most effective. The objective of this study is to answer these questions using nationally 
representative data.   
A comprehensive multi-level risk factor analysis for malaria infection in the DRC is needed 
in order to identify individuals who are at a higher risk for infection. No group has assessed risk 
factors for infection amongst adults in the DRC since the 2007. Several recent studies have 
demonstrated associations between various community-level factors and malaria risk amongst 
children in the DRC2,3. Thus, determining larger scale risk factors is critical for understanding 
malaria epidemiology, and an important part of creating intervention policies. Additionally, as 
several studies from across the world have demonstrated that malaria transmission dynamics 
differ between urban and rural areas, comparing risk factors between the two settings is another 
important element of targeting prevention efforts to be most effective4.  
Past work from the DRC has demonstrated the heterogeneous spatial epidemiology of 
malaria across the country, adding an additional complexity to prevention efforts. A study of 
adults in the DRC from 2007 demonstrated that malaria prevalence ranged from 0-82% 
depending on the region5. Additionally, while preliminary data from the Demographic and 
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Health Surveys (DHS) Program indicate that the national prevalence of malaria amongst adults 
remained steady from 2007 to 2013, the longitudinal differences in prevalence were highly 
variable across the country. Some provinces experienced a drop in prevalence since 2007 while 
others exhibited an increase. Understanding how and why these patterns of transmission are 
changing over time is necessary for identifying regions most in need of interventions. No studies 
have comprehensively investigated how the geographic distribution of malaria infection amongst 
adults has changed since in the past decade or linked these changes in malaria prevalence with 
intervention implementation.   
To address these gaps in knowledge we have formulated two Specific Aims for this 
study:   
Specific Aim 1: A) Determine individual and cluster-level risk factors for Plasmodium 
falciparum infection amongst adults living in the DRC and B) evaluate whether the effects 
of these risk factors are modified by urban/rural settings. Data will be derived from the 2013 
DHS. Plasmodium falciparum infection will be determined using a pfldh PCR assay. We will use 
the DHS data to build a multi-level model and estimate individual and community-level risk 
factors such as education or wealth index. Additionally, we will include the cluster-level 
proportion of drug resistant infections, determined by genetic sequencing, as a potential risk 
factor. Risk factors identified by this model will then be further assessed for modification by 
comparing strata specific risk estimates for both urban and rural areas (as designated in the 
DHS).  
Specific Aim 2: A) Compare the spatial distribution of patent Plasmodium falciparum 
malaria between 2007 and 2013 amongst adults in the DRC B) Assess the effects of 
community-level interventions on changes in patent malaria prevalence. Using data from the 
 3 
both the 2007 and the 2013 DHS, we will compare the prevalence and spatial distribution of 
patent Plasmodium falciparum infections (at least 100 parasites per uL of blood) amongst adults 
over time. We will create risk maps to identify whether province level prevalence increased or 
decreased between 2007 and 2013. Additionally, we will determine the effect of two malaria 
interventions, insecticide treated bed-nets and intermittent preventative therapy during 
pregnancy, with increasing or decreasing malaria prevalence between the two survey time points 
using geospatial Bayesian modeling.  
This proposal is innovative as it utilizes epidemiologic, genetic, and spatial data to 
determine risk factors for malaria infection. Additionally, it is the first study, to our knowledge, 
to evaluate longitudinal changes in national malaria prevalence amongst adults in the DRC, and 
to link these changes to specific interventions.  
The findings from this study will directly aid the DRC in its efforts to reduce malaria 
transmission; it will also have implications for other sub-Saharan African countries. Identifying 
risk factors for malaria infection will help direct intervention efforts to individuals at highest risk 
of infection. Understanding the heterogeneous spatial epidemiology of malaria within the DRC 
will help identify areas in which malaria transmission has increased over the past decade. Lastly, 
linking changes in malaria prevalence with interventions will help determine the effects of these 







CHAPTER TWO: BACKGROUND AND INNOVATION 
Malaria Overview:  
Malarial disease is caused by infection with the Plasmodium parasite, transmitted to 
humans through a bite from an infected female Anopheles mosquito. There are five Plasmodia 
species known to infect humans: P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi. 
Though most infections worldwide are caused by P. vivax, P. falciparum is responsible for the 
most deaths6,7. Symptoms usually manifest within 7-30 days after an infectious bite6. Typical 
symptoms of uncomplicated malaria include fever, chills, anemia and an enlarged spleen. 
However, some cases proceed to complicated malaria, which includes cerebral malaria and 
severe anemia6. Pregnant women can also develop placental malaria, potentially leading to 
premature delivery or a low birth weight baby6,8. Infections are treatable, although the available 
treatments depend on specific country policies.    
There are several methods for diagnosing malaria; the diagnostic of choice is largely 
dependent on context, cost, and feasibility. These methods are: rapid diagnostic tests (RDT), 
microscopy, clinical diagnosis, and polymerase-chain reaction (PCR). RDTs are point of care 
tests that only require a single drop of blood for diagnosis. The tests detect the presence of 
malaria antigens (most often the histidine-rich protein II antigen) in the blood and return a 
positive or negative result is about 15 minutes. Microscopy, considered the gold standard, 
requires a drop of blood to create a thick-smear microscope slide that is then read by a trained 
microscopist to determine the presence of parasites. Clinical diagnosis, as the name implies, is 
determined after a clinical evaluation in which a patient is assessed for the presence of typical 
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malaria symptoms such as fever, anemia, or an enlarged spleen. PCR is a laboratory based 
method that detects Plasmodium DNA from a patient blood sample. Though the most sensitive 
diagnostic, PCR requires specialized equipment and laboratory materials9. Each method presents 
pros and cons; the purpose of the diagnostic data and available resources often dictate which 
method will be used.   
 General risk factors for malaria disease include both biological and behavioral factors. 
Biological factors that influence risk include: younger age, human genetic factors (such as sickle 
cell trait), or previous infection10. Behavioral/societal influences include: lower income, 
agricultural exposure, and lack of proper housing10. While these factors are generally considered 
to be risk factors for disease, the relative effects of each of these may differ across populations. 
Studies from specific regions, as will be discussed further in the context of the Democratic 
Republic of the Congo, have also identified more individual and community-level risk 
factors2,3,5. Thus, findings from malaria studies tend to be specific to the specific context of 
study.   
The Global Burden of Malaria:  
Malaria remains a major public health problem worldwide. In 2018, there were 
approximately 228 million cases and 405,000 deaths due to malaria11. The global distribution of 
cases in 2018 demonstrates the wide geographic spread of malaria12,13 (Figure 2.1). Over 3 
billion people live in malaria endemic countries and are at risk for infection13. While the World 
Health Organization (WHO) reported an increase in the number of cases between 2015 and 
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2017, the estimates from 2018 indicate that the number of cases globally has since dropped 
slightly (228 million cases in 2018 vs. 231 million in 2017)11,14.  
 
 
Figure 2.1: 2018 global distribution of malaria worldwide. Countries in red reported at least one malaria 
case. Countries in yellow and blue reported zero cases in the past year (yellow) or previous three years 
(blue)11.   
 
Since 2000, with the creation of the Millennium Development Goals, there has been a 
significant reduction in malaria transmission worldwide and in Africa particularly15. In 2015, the 
Malaria Atlas Project (MAP), a consortium of researchers based at Oxford University, published 
a series of maps depicting the changes in malaria prevalence (detect by RDT) amongst children 
across Africa between 2000 and 201516. The maps, generated using a spatial-temporal Bayesian 
geostatistical model, indicate a steep drop in prevalence in many regions across the continent16 
(Figure 2.2). However, they also highlight remaining hotspots of malaria in West and Central 
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Africa16. MAP’s work highlights the enormous progress in malaria control over the past fifteen 
years, and identifies regions that will still need attention in the coming years.  
 
 
Figure 2.2: Estimated changes in malaria prevalence (as detected using RDTs) between 2000-2015 
amongst children ages 2-1016.  
 
The success of malaria control programs since 2000 are in large part due to significant 
increases in international investment. In the past two decades, there has been a nearly fifteen-fold 
increase in international spending on malaria control programs as well as research and 
development15,17. Nearly 2 billion dollars were invested in malaria programs in the WHO Africa 
region in 2016, an increase from 960 million per year over the past decade18. In the next decade, 
a further scale up of investment is planned to help more countries achieve elimination19. Thus, 
despite the recent uptick of cases, international attention and effort is focused on reducing 
malaria burden.  
Malaria Interventions: 
There are several methods for preventing malaria infection, each of which acts through a 
different mechanism to stop the spread of infection. Malaria interventions can be categorized into 
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three main groups: insecticide treated nets (ITNs), indoor residual spraying (IRS), and 
chemoprevention20. ITNs work in two ways, providing a physical barrier between an individual 
and the mosquito to prevent biting and by killing the mosquito with insecticide21,22. Many nets 
used today, called long lasting insecticide treated nets (LLINs), are specifically engineered to 
have extended insecticide efficacy22,23. The second option, IRS, involves spraying the inside of a 
building with insecticide to kill mosquitos24. This method targets a subset of Anopheles species 
that rest inside after taking a blood meal25. Lastly, many countries use chemoprevention methods 
by providing individuals, usually vulnerable groups such as pregnant women or children, with 
anti-malarial medication to prevent infection. Intermittent preventative therapy during pregnancy 
(IPTp) with Sulfadoxine-pyrimethamine (SP) is recommended by the WHO in areas of moderate 
to high transmission26,27. IPTp consists of providing all pregnant women with three doses of SP 
regardless of whether the woman is infected. Similarly, intermittent preventative therapy for 
infants (IPTi) consists of providing infants with three doses of SP within the first year of life 
regardless of infection status28. Some countries also implement seasonal chemoprevention during 
months of high transmission29. For this, WHO recommends using SP and Amodiaquine29. Many 
studies have assessed the efficacy of these interventions, demonstrating a range of protective 
effects across various geographic areas and transmission settings16,30,31. The choice of which 
interventions to use depends largely on the specific entomological and epidemiological 
environment, as well as available resources. 
Over the past two decades, researchers from across the world developed RTS,S, the first 
malaria vaccine shown to be protective against P. falciparum infection32. Phase 3 clinical trials 
for the vaccine concluded in 2014 and demonstrated that despite incomplete protection, there is 
still a net public health benefit of using the vaccine33,34. In 2017, WHO began a pilot program to 
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implement the vaccine in three countries (Kenya, Ghana, and Malawi) for children under the age 
of 2 years old32,35. As this program progresses, we will learn more about the effectiveness of this 
vaccine and its potential to help reduce transmission worldwide. Additional on-going research is 
investigating alternative vaccines such as those that block transmission of the malaria parasite 
rather than preventing infection36,37. These vaccines are still in development but are a promising 
avenue of research.   
Though these various intervention methods have all been shown to be generally 
protective against malaria, new threats to intervention efforts are spreading. First among these is 
resistance to many commonly used anti-malarial drugs including SP (the drug used for IPTp and 
IPTi). The history of malaria control is marked by the introduction of novel therapeutics, 
followed quickly by the development of resistance38. A recently completed study from our group 
using a subset of samples from children from the 2013 DRC Demographic and Health Survey 
estimated that 76% of the children with malaria had an infection with least one of the mutations 
shown to be linked with SP resistance39. Similarly, resistance to insecticides has led to decreased 
efficacy of LLINs and IRS40,41. Mutations of the mosquito genome block the insecticidal activity 
of the chemicals used to treat nets or used in IRS40. Though studies have shown that treated nets 
are still more protective than untreated nets in the presence of resistant mosquitos, rising 
resistance may seriously impact malaria control efforts41. Other roadblocks for prevention efforts 
are non-use and misuse of LLINs. A study from Ethiopia found that while 91% of survey 
respondents reported owning at least one net, only 65% reported that they had slept under the net 
the previous night42. The study also found a small number of communities in which nets were 
being used for purposes such as curtains, table cloths, or for farming42.These findings are 
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concerning and indicate the need to monitor the effect of various interventions in preventing 
transmission.   
Spatial Epidemiology of Malaria:  
Like other infectious diseases, malaria exhibits a complex spatial epidemiology, with 
transmission intensity differing across regions43. Countries are often categorized based on the 
level of transmission, for example: sustained year-long transmission, seasonal transmission, or 
low transmission43. However, these categorizations often mask within country heterogeneity. 
Many countries have some regions of high transmission and others of seasonal or low 
transmission5,44. In certain countries, this “micro-geographic” variation is observed even with a 
single city45. These heterogeneous dynamics are a result of various factors including differing 
vector populations across the country, ecological environments, and population density4,46–48. 
Different epidemiologic profiles within a single country indicate the need to study malaria on 
sub-national spatial scale.  
Spatial patterns of malaria transmission are in part driven by human mobility patterns. 
Infected persons can introduce malaria to new areas by traveling from an endemic region to a 
non-endemic region49. A study from Kenya used mobile phone data to identify specific “source” 
areas of high transmission from which people travel to “sink” areas of low transmission49. Work 
from Zambia demonstrated that individuals move to and from areas of high transmission even on 
a daily basis50. These findings complicate malaria control efforts, as human mobility can be 
difficult to monitor and is not an avenue for easily implementing interventions.  
Previous studies have investigated the spatial dynamics of malaria by examining parasite 
population structure, i.e.: is there evidence that parasite populations are made up of smaller, 
genetically distinct sub-populations? If so, how are these populations distributed over space? 
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Understanding population structure can help shed light on important questions, such as the 
degree of local versus national transmission. Recent studies have used genetic sequencing data to 
demonstrate that such structure does exist amongst P. falciparum populations in Southeast 
Asia51,52. The extent of this structure in sub-Saharan Africa is an area of active research as novel 
genetic and analytical tools are further developed53.   
Mapping of malaria prevalence across the world has become a hotbed of research as new 
statistical methods are developed. Though maps of malaria have existed for many decades, 
modern computing power has allowed the development of new geostatistical models, particularly 
those that use a Bayesian framework16,54–56. These models, used by groups such as MAP, have 
deepened our understanding of malaria epidemiology and highlighted avenues for future 
development16,55. Additional methods seek to link multiple types of data, such as parasite genetic 
sequencing data and cellphone records, to more accurately describe and predict local 
transmission patterns54.  
Urbanization and Malaria:  
Another element of the spatial epidemiology of malaria is the effect of urbanization. The 
growth of urbanization over the past century has helped contribute to the drop in malaria 
transmission worldwide, with one study from Hay et al estimating that urbanization lead to a 
6.7% reduction in deaths due to malaria57,58. Though many infectious diseases thrive in urban 
areas due to high population density, malaria prevalence is often much lower in cities than in 
rural areas59,60. This is largely a result of reduced vector populations in cities and lower biting 
rates. Better access to therapeutics, both for prevention and treatment, also contribute to lower 
transmission59. The drop in transmission within urban centers has largely shifted the burden of 
malaria to rural areas, a shift that has important implications for malaria control efforts4. Cities 
 12 
are vastly different from rural areas in terms of the ecological landscape and demographics, both 
of which contribute to malaria risk61. However, urban malaria should not be discounted as 
transmission does occur within cities60. The differing epidemiology of malaria between urban 
and rural areas indicates that malaria control efforts must be tailored to specific settings. 
The differences between urban and rural areas have also been shown to affect malaria 
control programs. A study from Myanmar demonstrated that ITN ownership and usage was 
higher amongst rural populations than urban62. Past work conducted in Liberia determined that 
the effects of bed-nets differed between the settings, with increasing community-level bed-net 
coverage being protective in urban areas but displaying no effect in rural areas63. The authors 
suggest that this difference could be due to a few reasons including: higher population density in 
urban areas (leading to increased density of nets), insecticide resistance in rural areas, or 
insufficient community-level LLIN use in rural areas63. Other studies from across sub-Saharan 
Africa have demonstrated that the protective effect of nets is lower in areas of higher 
transmission intensity, which is often true of rural areas64,65. These findings provide further 
evidence that control programs must be specific to each area as the effects of various 
interventions may differ by setting.    
Malaria in the DRC:  
The burden of malaria in the DRC is one of the highest in the world, with an estimated 25 
million cases in 201766. This represents over 10% of cases worldwide1. Transmission is 
characterized as holoendemic, indicating stable year-round transmission in 97% of the 
country20,67. The predominant parasite species is Plasmodium falciparum. Transmission is 
sustained by three Anopheles mosquito species: A. funestus, A. gambiae, and A. coluzzi67.  
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Though malaria is often considered a pediatric disease, adult cases remain a significant 
concern in the DRC. Estimates from the 2007 DHS indicate that the prevalence of infections 
amongst adults reached as high as 82% in certain regions of the DRC5 (Figure 2.3). These 
infections are especially important as most adults, particularly in countries of high transmission 
such as the DRC, do not exhibit symptoms68. Because of this, many of these infections go 
undiagnosed and untreated, remaining in the population and potentially capable of transmitting 
to others68,69. Additionally, though initially asymptomatic, there is evidence of long term health 
problems associated with such infections, including anemia, susceptibility to other infections, 
and cognitive damage70. Thus, adult cases are concerning in and of themselves, and must be 
























Figure 2.3: PCR-detectable malaria prevalence estimates from 2007 amongst adults in the DRC5. Areas 
of darker color indicate areas of higher prevalence; estimates range from 0 to 82%.  
 
Findings from genetic studies indicates that transmission within the DRC is complex and 
highly heterogeneous. The DRC, the second largest country in Africa, is considered a “melting-
pot” of malaria transmission, connecting East, West, and Central Africa71–73. Previous analyses 
have shown that parasites from the DRC are genetically similar to strains from both West and 
East Africa, indicating transmission between the DRC and its neighboring countries71,73. 
Additionally, the evidence regarding parasite population sub-structure in the DRC is mixed. 
Some studies have found no evidence of structure71,72, though others suggest that drug resistant 
parasites cluster together spatially39,53. Thus, the details of local transmission dynamics remain 
unclear. However, the overall picture is one of a complex environment of high transmission.  
 Like many other countries, the spatial distribution of adult malaria infections varies 
across the DRC. The country is divided into four epidemiologic zones: a mountainous region 
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with a very short transmission season, a tropical zone with high transmission during the rainy 
season, an equatorial region with high year-round transmission, and an urban zone with 
heterogeneous transmission (includes only the capital city of Kinshasa) (Figure 2.4)20. As stated, 
prevalence estimates from 2007 range across regions from as high as 82% to as low as 0%5 
(Figure 2.3). Additionally, there is evidence of heterogeneity between urban and rural areas, as 
the prevalence of infection amongst children living in rural areas was found to be higher than 
that amongst children in urban areas2. These dramatic differences make it more difficult to plan 
intervention programs, as different regions have vastly different needs. Understanding the drivers 
of these spatial differences is a key element of reducing transmission.  
 
 
Figure 2.4: Map of epidemiologic zones in the DRC: the mountain region with a short transmission 
season (green), tropical zone with high transmission during the rainy season (red), the equatorial region 




Risk factors for malaria in the DRC:  
Given the high burden of malaria, determining risk factors for infection is critical for 
identifying individuals or groups more likely to become infected. Several studies have performed 
such analyses in the DRC, identifying both individual and community-level risk factors for 
infection (Table 2.1) 2,5,73. The most recent analysis of adults was conducted using data from the 
2007 DHS; multiple analyses of children have been conducted more recently using data from the 
2013 DHS.  
 
 
Table 2.1: Previously identified risk factors for malaria in the DRC  
 
Level  Risk Factor Association Group studied Study year  
Individual  Age Older age is protective   Adults and 
children  
20075, 




wealth is protective  
Adults  20075  
Female Sex Found to be both 
protective (adults) and 




20133   
Recent Fever Recent fever associated 
with increased risk  





during last pregnancy is 
protective  
Adults  200773 
Bed-net use Individual bed-net use is 
protective  
Adults and 
children   
20075, 20132  
Community  Wealth  Increasing community 
wealth is protective 
against infection in 
general, found to be 
associated with increased 
prevalence of drug 
resistant infections 
Adults and 
children   
20075, 201339 
Education Increasing community 
education associated with 
increased prevalence of 
drug resistant infection  
Adults and 
children   
2007, 201339 
Bed-net use  Increasing community 
bed-net use is protective  




These various factors highlight the multi-faceted nature of malaria and the many different forces 
that drive transmission. They also highlight potential inconsistencies in the literature (such as the 
effect of female sex or community-level wealth).  
Interventions in the DRC:  
  
In the DRC, bed-nets and IPTp are two main components of the malaria intervention 
program20. The Ministry of Health began a national ITN and LLIN rollout campaign in 200775. 
In 2008, the World Bank financed a program to distribute ITNs to Kinshasa specifically75. 
Reported ITN and LLIN ownership increased between 2007 and 2013 from 28% to 72% and 9% 
to 70%, respectively2,76. Additionally, IPTp using SP is recommended for all pregnant women, 
though estimates from 2013 indicated that only 14% of pregnant women reported receiving at 
least two doses of SP (three doses are recommended)20,26,77. These programs are supported by 
groups such as The World Bank as well as The President’s Malaria Initiative and Santé Rural, 
two health organizations working in the DRC20,78. As the burden of malaria remains high within 
the DRC, the actual protective effects of these intervention programs need to be investigated.  
There is no current national IRS program in the DRC. Limited IRS programs are 
conducted by a few privately-owned mining companies located in the southern provinces; 
however, these are very localized programs79. In 2017, approximately 36,000 households were 
included in an IRS program carried out in Luabala province80. Future malaria control programs 
may include IRS, though this would require extensive entomological monitoring80.  




200773, 20133  
Precipitation  Increasing precipitation is 
protective  
Children 20133 
Agriculture  Increasing agricultural 
land cover increases risk  
Children  20133 
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 Several studies from the DRC have demonstrated that community-level interventions are 
associated with reduced malaria risk more so than individual interventions. This has most clearly 
been demonstrated in the case of bed-nets, where increasing community bed-net coverage was 
associated with a larger individual protective effect than individual bed-net use amongst 
children2,3. A 2014 study of all-cause child mortality (ACCM) in seventeen African countries 
(including the DRC) found that the protective effects of individual ITN ownership depended on 
community-level ITN coverage; individual ITN ownership was only associated with decreased 
hazard of ACCM in areas with >30% community ITN use81. The same study found that 
community ITN coverage above 50% was protective against malaria amongst children without 
ITNs within their households, though this specific analysis did not include the DRC81. The 
finding that one person’s protection helps protect others is not surprising, and has in fact been a 
part of intervention planning for many infectious diseases for many years. However, the extent to 
which community-level coverage of other interventions, such as IPTp, affect malaria risk 
amongst adults in the DRC has not been explored. 
Overview of spatial modeling:  
Often, health data are spatially correlated, meaning that disease outcomes within certain 
geographic areas are likely to be similar82. In many cases, individuals who live close to each 
other have outcomes more similar to each other than those who live farther away. This is not 
surprising since people who live near each other are exposed to the same environmental factors, 
interact with each other such that they spread infectious diseases, or are similar demographically. 
Understanding this spatial dependence is not only valuable in and of itself, but it is also critical 
for properly estimating any exposure/outcome associations that exist within the space. The 
fundamental assumption of generalized linear models is that of independent observations; 
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spatially correlated observations violate this assumption. Luckily, the disciplines of geostatistics 
and spatial epidemiology specifically work to address this problem.  
There are several approaches that have been developed to properly model spatial data and 
the literature on these topics is vast. A discussion of these methods could (and does) span 
multiple textbooks, so here we will only briefly discuss the methods we used in our analyses. In 
this dissertation, I primarily utilized Conditional Auto Regressive (CAR) modeling. CAR models 
are useful in a setting in which data are aggregated to a set of non-overlapping areal units such as 
states, counties, or districts83. Data from areas that are neighbors are assumed to be more highly 
correlated than those from areas that are not. Multiple groups have proposed various 
specifications of this type of model and specifics regarding the models used in this dissertation 
are provided in Chapter Four. Additional modeling methods that we explored, though ultimately 
did not include in the analysis, are Spatially Varying Coefficients (SVC) modeling. First laid out 
by Gelfand et al in 2003, SVC methods allow exposure/outcome associations to vary over 
space82,84. This not only more accurately estimates associations than non-spatial models, but also 
allows us to discern patterns of effects across space. For example, Wheeler et al demonstrated 
that the association between the number of alcohol outlets within a neighborhood and the violent 
crime rate changed considerably across the study area (the city of Houston), with increasing 
alcohol outlets displaying a protective effect in some neighborhoods but a harmful effect in 
others82. These methods are necessary to properly assess and address spatial autocorrelation, and 
the choice of proper methods is determined by the research question and available data.   
Innovation:  
This dissertation is innovative in several ways. First, we combined multiple forms of 
data: demographic data from the DHS, genetic drug resistance data, and geospatial data, bridging 
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the fields of epidemiology, genetics, and spatial statistics. Additionally, this study is the first to 
use nationally representative PCR data to study changes in malaria prevalence in the DRC. As 
PCR is expensive to conduct, and requires a laboratory and trained technicians, it is not 
commonly used as a diagnostic for malaria. However, it is the most sensitive diagnostic tool 
available9. Additionally, this is the first study to compare changes in malaria prevalence over 
time amongst adults in the DRC. It is also the first study, to our knowledge, to evaluate the 


























CHAPTER THREE: SPATIAL AND EPIDEMIOLOGICAL DRIVERS OF P. 
FALCIPARUM MALARIA AMONG ADULTS IN THE DEMOCRATIC REPUBLIC OF 
THE CONGO 
Introduction:  
Malaria remains an important cause of morbidity and mortality in the Democratic 
Republic of the Congo (DRC), which is home to 12% of all cases globally85. Understanding 
malaria transmission in the DRC is critical for furthering efforts to eliminate malaria in sub-
Saharan Africa. In addition to the high disease burden, there is evidence that the DRC acts as a 
bridge of transmission, connecting parasites from East and West Africa72,73,86. To combat 
transmission and reduce disease burden, it is important to determine risk factors for infection. 
These factors can be used to identify individuals or groups more likely to become infected and, 
therefore, more likely to benefit from programmatic interventions. Adult infections remain 
understudied, as most malaria deaths occur amongst children87,88. However, adults are frequently 
infected, often asymptomatically, and may serve as a reservoir for transmission68,69. Yet, we 
know very little about risk factors for infection in adults. In this study, we assessed malaria risk 
factors amongst adults using data from over 16,000 participants from the nationally 
representative 2013-2014 Demographic and Health Survey (DHS) conducted in the DRC, the 
largest and most recent health survey conducted in the country.  
A small number of studies performed in the DRC have identified important risk factors 
for infection2,3,73. These studies showed that increasing age, wealth, and individual bed-net use 
are protective, as are increasing community-level bed-net use, lower average temperature and 
higher altitude2,3,74,89. However, these studies included only children under the age of five2,3, or 
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were small and geographically limited74,89. A study of adults in the DRC conducted using data 
from the 2007 DHS identified several risk factors, such as younger age, male sex, and lower 
individual and community-level wealth5; however, no nationally representative risk factor 
studies of adults have been conducted since.  
 In this study we evaluated current individual, household, community, and environmental 
risk factors for malaria amongst adults. Additionally, because increasing antimalarial drug 
resistance is a growing concern in the DRC, we sought to understand the relationship between 
community-level resistance and infection prevalence39,53. Similarly, the association between 
increasing antimalarial use and malaria prevalence amongst adults has not been studied in the 
DRC. Understanding the role of these factors is critical for determining drivers of malaria 
infection. The different scales of the factors demonstrate the various levels at which malaria 
interventions can be targeted. 
This study builds on previous work in the DRC by evaluating the role of urbanization on 
risk factors for infection. Understanding the effect of urbanization on malaria transmission is a 
critical part of intervention planning4,57,58. Unlike other infectious diseases, which thrive in cities 
due to increased population density, malaria transmission is often lower in urban areas as 
compared to rural areas59,60. This is due to several factors, including reduced vector populations, 
lower biting rates, and better access to therapeutics59. As a result, the effects of malaria control 
programs have been shown to differ between cities and rural areas. Multiple studies conducted in 
Nigeria and Benin found that bed-net ownership and use were higher amongst rural populations 
than urban90–92. Past work conducted in Liberia determined that the effects of bed-nets differed 
between the settings, with increasing community-level bed-net coverage being protective in 
urban areas but displaying no effect in rural areas63. We explored this relationship in the DRC by 
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assessing whether the effects of various risk factors for infection differed between individuals in 
urban versus rural areas.   
 The findings from this study can be used to identify individuals and communities at 
higher risk for malaria infection in the DRC. They also shed light on differences in the 
epidemiology of malaria between urban and rural settings. 
Methods:   
Study Population: The data for these studies were drawn from both the 2007 and the 
2013-2014 Demographic Health Surveys (DHS) conducted in the Democratic Republic of 
Congo. The DHS Program, run by USAID in conjunction with local governments, carries out 
cross-sectional surveys in over 90 countries93. In the DRC, the DHS is conducted by several 
governmental ministries, using a nationally representative randomized cluster sampling 
method76. First, sampling cluster sites were selected from a map of enumerated areas across the 
country with the probability of selection proportional to the size (number of households) of the 
cluster. Next, households were randomly selected for inclusion from within clusters94. Cluster 
sizes differ between urban and rural areas with approximately 5 – 15 more households included 
in rural areas94. To account for this nested cluster sampling strategy when analyzing the data, 
each cluster was assigned a sampling weight. DHS survey conductors visited selected 
households, obtained consent, and administered an extensive questionnaire covering a broad 
range of topics including nutrition, education, health history, and infectious diseases76. 
Geolocation data were also recorded for each cluster and randomly jittered between 2 and 10 
kilometers. Blood spots were saved on filter paper and shipped to The University of North 
Carolina for PCR diagnostic testing.  
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A total of 18,257 adults from 12,549 households were included in the 2013-2014 survey 
and asked to provide blood samples. This included 9,601 women (ages 15-49) and 8,656 men 
(ages 15-59). In addition, 9,790 children (ages 6 months to 5 years) were part of the survey. 
Although they were not included in this analysis, they have been examined previously2,3,9.  
Risk factor selection and modeling: Potential risk factors P. falciparum infection were 
determined by consulting previous studies and based on biological plausibility. We selected 
individual, household, and cluster (community) level risk factors that have demonstrated 
associations with malaria risk 2,3,5. Individual factors included age, biological sex, HIV infection 
status, education, and wealth index. The DHS Program calculates wealth index as a composite 
variable based on each household’s assets and housing materials95. Using Principal Components 
Analysis (PCA), participants were then grouped into wealth quintiles: poorest, poor, middle, 
rich, and richest95. We also assessed bed-net use, which was determined by whether the 
individual reported sleeping under a long lasting insecticide net (LLIN) the previous night. At 
the household level, we constructed a “net ratio” variable by dividing the number of total nets 
per household by the number of individuals within the household. This was then dichotomized 
into ratios of less than 0.5 versus those of 0.5 or higher (i.e.: at least one net for every two 
household members). We also created a composite “housing materials” variable, dichotomized 
as either traditional or modern, based on data from the roof, wall, and floor material variables 
(further details are available in Appendix A)96. A recent study from The Gambia demonstrated 
that metal roofs were protective against malaria infection97, thus we also assessed the 
relationship between malaria and metal roofing alone, separate from modern housing. Cluster-
level factors included proportion reporting LLIN use, median wealth index, and median 
education level. We also assessed average annual precipitation and temperature as well as the 
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range in temperature (defined as the difference between the average temperature in January and 
average temperature in July) and the cluster vegetation index98.. Data were drawn from the DHS 
questionnaire as well as from the DHS Program, which collects a range of environmental and 
geological data98.  
PCR diagnosis: The primary outcome for Aim 1 was P. falciparum malaria infection as 
determined by real-time PCR. In this Aim, malaria is defined as infection with P. falciparum 
parasites. PCR was performed on the blood-spots collected as part of the DHS survey. Whole 
blood collected by finger-prick was spotted onto Whatman filter paper, dried at ambient 
temperature, and initially stored with desiccant at -80C in Kinshasa until punching (one 6mm 
punch per subject) and shipment to UNC. DNA was extracted from the blood spots using a 
Chelex extraction assay and used for PCR testing99. The PCR assay detects the P. falciparum 
lactate dehydrogenase gene (pfldh) with a limit of detection of 5-10 parasites/mL100,101. The 
human beta-tubulin (HumTuBB) gene was used as a positive control, and any samples that failed 
to amplify HumTuBB were excluded. The duplexed pfldh and HumTuBB quantitative PCR 
assay was performed using reaction conditions, primers, and quality control measures for high-
throughput PCR exactly as previously described101. All samples were run in duplicate. Samples 
that amplified pfldh in only a single replicate were considered negative if the cycle threshold 
value was higher than 38. All laboratory assays were completed at the University of North 
Carolina at Chapel Hill.  
Genetic analyses: Community-level drug resistance was determined using second-
generation sequencing data obtained using molecular inversion probes (MIPs) that target known 
molecular markers of resistance to antimalarial drugs53. MIPs are a technology for obtaining 
highly multiplexed deep sequencing data that have recently been applied to Plasmodia species53. 
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Using previously generated sequencing data from 1,065 children enrolled in the 2013-14 DRC 
DHS39,53, we assessed single nucleotide polymorphisms (SNPs) of the pfdhps (A437G, K540E, 
and A581G) and pfcrt (K76T) genes known to be associated with sulfadoxine-pyramethamine 
(SP) and chloroquine resistance, respectively53,102–104. We used these individual-level data to 
estimate cluster-level prevalence for each SNP using the PrevMap package in R, which fits a 
spatial model using a Gaussian Process105. We fit the model to generate estimates of the 
underlying allele frequency distribution using maximum likelihood and running 10,000 
simulations. Further model details are available in Appendix A.  
Urban/rural classification: Potential misclassification of urbanicity is a concern in large 
surveys with complex sampling frames106. In order to minimize such misclassification, we 
conducted a PCA incorporating variables with a demonstrated relationship to urbanicity 49,98,107. 
These variables were: degree of built environment, nighttime lights, total population as of 2014, 
population density as of 2014, and estimated travel time to the nearest city. The DHS collects 
these data from a variety of remote sensing and modeling databases including: WorldPop, the 
Joint Research Centre, and the Climate Research Unit at the University of East Anglia 98,108–110. 
The DHS collects these variables for each cluster; all variables were scaled and log transformed 
for the analysis. From the PCA, we extracted the values for the first principal component (PC) 
for each cluster, and generated a new urban/rural variable by dichotomizing the PC1 value at the 
75% percentile (e.g., urbanicity is represented by the upper quartile of PC1). The new measure of 
urbanicity was used to assess differences in risk factors between urban and rural areas. We 
compared the classifications generated for this analysis to the urban/rural categorizations from 
the DHS using Pearson’s correlation coefficient. 
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Modeling and statistical analyses: All analyses were performed using the R statistical 
platform v. 3.5.2111. We assessed the relationship between each risk factor and PCR detectable 
malaria infection using bivariate log-binomial regression models (i.e. not adjusted for other 
variables) to estimate prevalence ratios. We fit models incorporating sampling weights using the 
survey package in R, which uses weighted generalized estimating equations to properly account 
for the multi-level sampling scheme and correlation between individuals in the same sampling 
cluster112,113. This allowed us to assess individual and cluster-level factors simultaneously. As 
most households had only one adult member, we did not need to account for within-household 
correlation. We used bivariate models as the aim was to assess marginal associations, not causal 
relationships114. Each identified risk factor was then further assessed to determine if the 
association with malaria prevalence differed by urban/rural status by including the urban variable 
and an interaction term between each factor and the urban variable in the model. As done 
previously for MIP genetic data, we generated spatially smoothed prevalence and standard error 
estimates using the PrevMap package (Appendix A)105. 
In addition to the risk factor modeling we conducted several subsequent analyses. As the 
DHS asks multiple questions regarding bed-net use, we conducted a sensitivity analysis to 
compare various coding methods for net use. Further details are presented in the Appendix A. 
We also assessed whether the association between individual net use and malaria risk differed 
across categories of overall cluster malaria prevalence. For this analysis, we used previously 
published data from children included in the 2013-2014 DHS to determine community-level 
prevalence in order to avoid including the outcome data of adult infections from 2013 in 




Our analysis included 16,126 adults from the original 18,257 initially selected for 
inclusion in the DHS. Individuals were sampled from 533 geographically dispersed clusters; 
GPS data were missing for 44 clusters, resulting in 489 clusters for analysis (Figure 3.1). 
Characteristics describing the individuals with missing GPS data are available in Supplemental 
Table A2. After final data processing, 16,363 individuals had complete PCR and DHS covariate 
data. Two-hundred and thirty-seven individuals were not considered “du jure” (members of the 
sampled household, rather than visitors who slept in the household the previous night115) and, 
thus, were not included in the analysis, resulting in a final data set of 16,126 individuals (Figure 
3.2). Overall PCR prevalence of P. falciparum infection was 30.3% (SE = 1.1). The results of the 
PrevMap analysis demonstrated the high spatial heterogeneity of infection; community 
prevalence estimates ranged from 0-76% (Figure 3.3). The map of the model standard errors 
indicated low variance in the estimates across the DRC (Supplementary Figure A1). Prevalence 
estimates by province ranged from 6.7% in Nord-Kivu to 58.3% in Bas-Uele (Supplementary 
Table A1).  
Reported bed-net use was low; though 75% of adults reported owning a LLIN, only 54% 
reported sleeping under a net the previous night. The average ratio of nets per household member 
was 0.27, indicating approximately one net per four household members. Only 17% of adults 
lived in houses with at least one net per two household members; 24% of all households had at 
least one net for every two people. Baseline characteristics of study participants are presented in 









































































Figure 3.3: Map of predicted P. falciparum PCR prevalence estimates. Smoothed prevalence estimates, 
incorporating the sampling weights, were generated using the PrevMap package in R39. Predicted 
proportions range from 0-0.76.  
 
Risk factor analysis: Several covariates were associated with prevalence of malaria 
infection (Table 3.2). Individual protective factors included: increasing age, female sex, 
increasing education, and increasing wealth index. Protective household factors included living 
in a house made of modern housing materials and having a metal roof. At the cluster-level, 
increasing median wealth index was protective. Higher use of SP amongst pregnant women at 
the cluster-level was also found to be associated with lower prevalence of malaria. Drug-
resistance mutations were more common in low-prevalence clusters. Increasing average 
temperature was associated with increased prevalence of infection as was increasing vegetation. 
A larger range in average monthly temperature was associated with lower malaria prevalence. 
Full risk factor modeling results are available in Table 3.2.  
We found a modest protective association of individual LLIN use and no effect of 
increasing community LLIN use, in contrast to previous findings in the DRC2.  At the household 
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level, a net ratio greater than 0.5 (i.e. at least one net per two household individuals) was 
protective, compared to households with a lower ratio. When we stratified individual net use by 
insecticide type, we observed a protective effect of deltamethrin-treated nets and a signal for 
protection with alphacypermethrin nets. There was no significant protective effect of permethrin-
treated nets, a finding that has been previously reported for children in the DRC2. Restricting 
LLIN use to only those who had reported using a net treated with deltamethrin or 
alphacypermethrin, we found a slight protective effect of increasing community-level net use. 
The sensitivity analysis of net use showed no differences between measurement options or the 
coding choice for net use (Supplemental Figure A1). Additionally, the sensitivity analysis 
showed no difference in the association when restricting “net-use” to only nets under 3 years old. 
A comparison of individual LLIN net use between adults and children included in the 2013-2014 
DHS indicated similar protective effects (Supplementary Table A4). 
Analysis of Associations by Urban/Rural status:  There were several socioeconomic-
related risk factors whose association varied by urban/rural status (Figure 3.4). These included 
individual-level wealth, with increasing wealth showing a protective effect in urban areas but not 
rural. A similar trend was observed for increasing individual-level education. Additionally, both 
modern housing and metal roofs were protective in urban areas but not in rural areas. Cluster-
level wealth demonstrated problematically high collinearity with urbanicity and thus could not be 
modeled. Full numeric results from this analysis are presented in Supplemental Table A3.  
Overall, urbanicity did not impact the association between LLIN use and malaria 
prevalence, either at the individual or cluster-level. However, when we subset LLIN use to only 
deltamethrin and alphacypermethrin nets, the only insecticides that demonstrated a protective 
effect in the initial analyses, we observed that increasing individual and community use of these 
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nets were more protective in rural areas than in urban areas. Similarly, the analysis of LLIN use 
by cluster-level prevalence found that individual net use was more protective in areas of higher 
overall malaria prevalence (Figure 3.5).  
The correlation between the urban/rural categories generated for this analysis and the 
original DHS categories was 0.75. 
 
Figure 3.4: Results of the analysis comparing risk factor effects between urban versus rural areas. 
Prevalence ratios and confidence intervals by urban status are presented for each risk factor. Urban results 
are presented with blue triangles, rural results with red circles. Differences in point estimates indicate 
differences of the prevalence ratio by urbanicity. The associations of several factors, such as modern 
housing, education, and wealth, demonstrated differences between urban and rural areas. The null value 












Figure 3.5: Effect of individual bed-net use by cluster-level malaria prevalence. We used previously 
published data from children included in the 2013-2014 Demographic and Health Survey in order to 
determine cluster-level prevalence9. Individual bed-net use was more protective in clusters with higher 
malaria prevalence. The null value (Prevalence Ratio = 1) is indicated with a horizontal dashed line. 
 
Discussion:  
In this study, utilizing data from the largest and most recent nationally-representative 
health survey conducted in the DRC, we found a high national prevalence of P. falciparum 
malaria (30%) amongst adults. We also found high spatial heterogeneity. Community-level 
prevalence estimates reached as high as 76%. Malaria is often considered a pediatric disease as 
the majority of deaths occur amongst children87. However, our findings emphasize that the 
burden of disease amongst adults is high in the DRC and highlight the importance of adult 
infections in malaria epidemiology. Addressing adult infections is critical for eliminating malaria 
as adults may serve as a reservoir for further transmission of parasites68. The high level of spatial 
heterogeneity across the country underscores the need to study malaria on a sub-national scale 
and develop targeted strategies for areas of highest prevalence (and thus a larger reservoir). The 
spatial distribution of infections amongst adults matches that of infections amongst children 
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included in the 2013-2014 DHS, indicating similar underlying spatial processes116. Similarly, the 
prevalence map displays similar a pattern to that from adults included in the 2007 DHS5. The 
areas of high versus low prevalence are likely driven by several factors such as altitude and 
urbanicity. The mountainous regions of Kivu in the northeast have very little malaria, while the 
mining districts in southern DRC have higher prevalence. 
The national prevalence estimate of 30% amongst adults is similar to that from the 2007 
DHS, suggesting a need for increased investment in malaria control in the DRC and further 
understanding of drivers of transmission5,85. We observed that the prevalence is unchanged from 
2007 despite increases in LLIN coverage and the number of individuals being tested and treated 
for infection85. Thus, understanding malaria risk factors in all age groups remains critical for the 
design and implementation of effective interventions. Several risk factors identified in an 
analysis of the 2007 DHS data were also associated with increased infection prevalence in this 
study, highlighting their continued importance in the epidemiology of malaria. These include 
younger age, male sex, and lower community-level wealth5. The factors identified in this study, 
many of which have also been identified in other countries10,117,118, are particularly important for 
identifying infected individuals in the DRC, as many adult infections are asymptomatic and often 
go undetected68. Thus, targeting malaria interventions towards younger adults, men, and poorer 
communities could maximize their impact.  
In this study, we found that individuals living in households with a bed-net ratio greater 
than 0.5, i.e.: at least one net for every two household members, had lower prevalence of malaria. 
This ratio is recommended by the WHO in order to ensure a sufficient number of nets for 
household members14. Though previous studies have assessed the role of increasing community-
level net use, the effect of within household “net coverage” has not been studied, to our 
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knowledge. Our findings demonstrate the importance the number of nets within a household and 
support the WHO recommendation. However, only 24% of households in 2013-2014 DHS had a 
net ratio of 0.5 or higher. The 2019 WHO World Malaria Report estimated that currently, 
approximately 50% of households in the DRC have at least one net for every two people11. Thus, 
the DRC is making progress towards achieving the WHO recommendation; however, there is 
still a lot of work to be done to make sure all households meet the recommendation. It is critical 
that future bed-net distribution campaigns ensure that enough nets are provided to each 
household.   
 In this analysis we did not observe the overall protective effect of community bed-net use 
that has been previously demonstrated amongst children in the DRC, though there was a 
protective effect of increasing community use of deltamethrin and alphacypermethrin treated 
nets2. As mentioned, we did see a protective effect of increasing within household net coverage, 
which may be a more important factor for reducing infection than community net use. Our 
findings of greater protection from nets in higher prevalence areas and in rural areas are 
supported by a recent meta-analysis that found increasing community malaria prevalence 
associated with a greater protective effect of LLIN use (OR = 0.80) 119. Thus, bed-net distribution 
campaigns may be more successful in rural or generally higher prevalence areas than in cities.  
Poor LLIN efficacy may be due to several factors such as adult sleeping behaviors and 
changing mosquito biting patterns, and demonstrates that malaria control programs cannot rely 
on LLIN use alone. Many adults go to sleep after Anopheles mosquitoes begin biting, rendering 
LLINs less useful120. Additionally, recent studies have demonstrated a shift in Anopheles biting 
hours earlier in the evening as a result of LLIN use121. These findings point to the need to 
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consider additional malaria control programs such as improved community testing for malaria 
and targeted mass drug administration122–124.  
The findings from the genetic analysis of mutations associated with SP and chloroquine 
resistance indicate that areas of higher prevalence of drug resistance had lower prevalence of 
malaria infection. While this is a marginal association and does not reflect a causal relationship, 
this could be due to the amount of anti-malarial drug use, leading to lower overall prevalence of 
malaria but increased resistance through increased selective pressure. Future studies should aim 
to investigate the causal effect of increasing community-level drug resistance on malaria risk; 
however, this was not the primary aim of this study. Additionally, cluster-level SNP prevalences 
were modeled estimates generated using data from children and thus may not be representative 
of overall community-level prevalence. 
Modern housing and metal roofing were both associated with lower prevalence of 
malaria, though the association was more pronounced in urban areas than in rural areas. The 
effect of metal roofing agrees with findings from a recent study conducted in the Gambia, which 
found 38% lower mosquito survival and lower malaria prevalence amongst villages with higher 
proportions of metal roofs125. The authors of the study propose that this is due to the higher 
temperatures of metal roofs during the day, leading to lower mosquito survival. The present 
findings suggest that housing improvements may help reduce malaria risk, either directly as 
proposed by the Gambian study, or indirectly through overall improvements in living conditions 
and socioeconomic status.  
This study also highlights differences in the epidemiology of malaria between urban and 
rural areas, confirming the need to tailor interventions to different populations in cities versus 
rural areas. Increasing wealth and education are both highly protective in urban areas but not in 
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rural areas. This may be a result of increased access to prevention and treatment methods in 
urban areas, as has been observed in other countries. A study from Equatorial Guinea found 
individuals in rural areas waited longer to seek treatment for malaria infections compared to 
those in urban areas, and were more likely to be treated at home rather than in a health facility126.  
These results also agree with findings from previous studies that poor individuals living in urban 
areas have similar health risks to the general rural population58. Thus, in urban areas, the malaria 
positive population is poorer and less educated than those infected in rural areas. Malaria control 
programs should take these differences in high-risk populations into account, targeting poorer or 
less educated individuals in cities and ensuring that interventions are accessible for these 
populations. Conversely, interventions in rural areas need to be more widespread and accessible 
to a more diverse population.  
This study has several strengths. First, it uses nationally-representative, population-based 
data from over 16,000 individuals, the largest health survey conducted in the DRC. This allows 
us to make inferences regarding the country as a whole. Other recent malaria risk factor studies 
have fewer individuals or are conducted in a smaller geographic area74,89. Second, we determined 
malaria infection using high-throughput real-time PCR, the most sensitive method for diagnosing 
infection9. Third, it leverages country-wide drug resistance genotyping data to inform 
community-level epidemiological analysis. Lastly, this study incorporates multiple types of data 
including: survey, molecular, deep sequencing drug resistance, and geospatial data collected at 
the individual, household, community, and environmental level. This allowed us to demonstrate 
the different scales of malaria risk factors; control programs should aim to intervene at each of 
these levels.  
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The findings from this study are subject to limitations. Several of the covariates included 
in the study were obtained from self-reports, including LLIN usage. While self-reported data are 
subject to recall bias, the DHS questionnaire asks multiple questions regarding net use that 
allowed us to assess bias. The sensitivity analysis comparing these questions indicated no 
difference in modeling results between the questions, providing confidence that bias from self-
reports is minimal. Secondly, this analysis evaluated marginal associations and thus the findings 
cannot be interpreted as causal effects. However, the associations are useful for identifying and 
targeting interventions to higher risk individuals and groups such as younger, less educated men. 
Additionally, as the DHS is a cross-sectional survey, we did not assess the effects of seasonality. 
Finally, we could not directly assess the epidemiology of symptomatic malaria in the DRC as 
DHS surveys do not sample health facilities. 
Conclusion: 
This study evaluated risk factors for P. falciparum infection amongst adults in the DRC 
using data from the nationally representative, population based DHS survey. Overall prevalence 
of infection was high, 30%, and grossly unchanged from the prior 2007 survey. We observed 
high spatial heterogeneity across the country and identified individual, household, and 
community-level risk factors for malaria such as male sex, traditional housing, and decreased 
within household net coverage. These findings support the need for sustained investment in 









Table 3.1: Descriptive statistics of the study population by P. falciparum PCR status  
 
 PCR-positive PCR-negative Total 
Unweighted total number*  5,372  10,754 16,126 
Weighted Proportion**  30.3% 69.7%   
Individual Level**:         
Median Age (IQR) 26 (19-36) 29 (21 - 38)  28 (29-38) 
Number Female (%) 2,360 (47.6) 6,202 (54.4) 8,562 (52.3) 
Number HIV positive (%) 30 (0.6) 126 (1.1) 156 (0.9) 
Education Category (%)       
   No school 515 (10.4) 1,140 (10.0) 1,655 (10.1) 
   Primary school 1,618 (32.6) 3,346 (29.4) 4,964 (30.4) 
   Secondary school 2,662 (53.8) 6,079 (53.4) 8,741 (53.5) 
   Higher than secondary  156 (3.2) 826 (7.2) 982 (6.0) 
Owns a bed-net (%) 3,615 (72.9) 8,589 (75.3) 12,204 (74.6) 
Slept under bed-net previous night 
(%) 
2,462 (49.7) 6,422 (56.3) 8,884 (54.3) 
Wealth Category (%)       
   Poorest 1,059 (21.4) 1,840 (16.1) 2,899 (17.7) 
   Poor 1,030 (20.8) 2,014 (17.7) 3,044 (18.6) 
   Middle 1,122 (22.6) 2,124 (18.6) 3,246 (19.8) 
   Rich 1,041 (21.0) 2,249 (19.7) 3,290 (20.1) 
   Richest 704 (14.2) 3,178 (27.9) 3,882 (23.7) 
Household Level:      
Average number of bed-nets per 
person (SE) 
0.25 (0.07) 0.27 (0.08)  0.26 (0.07) 
Modern Housing (%) 593 (12.0) 2,514 (22.1) 3,107 (19.0) 
Metal Roofing (%) 1,564 (31.6) 5,147 (45.1) 6,711 (41.0) 
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Cluster-level**:       
Median Age (IQR) 30.0 (28.5 – 31.3) 29.7 (28.2 – 31.0)   30.0 (28.6- 
31.6) 
Urban (%) 1,329 (26.8) 4,297 (37.7) 5,626 (34.4) 
Median Education (IQR) 2 (1-2) 2 (1-2)  3 (2-3) 
Median Wealth Score (IQR) 3 (2-4) 3 (2-5)  3 (2-4)  
Average Annual Centimeters of 
Precipitation (SE) 
152.2 (1.4) 149.9 (1.7) 150.6 (1.4) 
Average Temperature (SE) 24.7 (0.1) 23.7 (0.2) 24.0 (0.2) 
Vegetation Index***  3934.5 (52.6) 3660.7 (69.5) 3734.6 (58.7) 
% Drug Resistance****:       
    Any pfdhps   92.2 (0.7) 95.1 (0.4)  94.2 (0.5) 
    pfdhps K540E 23.5 (1.7) 32.9 (2.5) 30.1 (2.1)  
    pfdhps A581G 1.8 (0.1) 3.9 (0.4) 3.2 (0.3)  
   pfcrt K76T 56.0 (2.3) 64.8 (1.9) 62.1 (1.8)  
% Net Ownership (SE) 73.7 (1.3) 75.0 (1.5)  74.6 (1.3) 
% Net Usage (SE) 52.7 (1.4) 54.6 (1.6) 54.0 (1.4)  
% SP use amongst pregnant 
women (SE) 
25.3 (1.3) 28.0 (1.1) 27.2 (1.1)  
 
*These are unweighted raw numbers and do not represent the sum of the subsequent values in the table as 
subsequent values incorporate sample weights 
**Proportions and numbers with sampling weights applied  
***vegetation index ranges from 0 (least vegetation) to 10,000 (most vegetation)98 















Table 3.2: Risk factor analysis results  
  
Variable Prevalence Ratio 95% Confidence 
Interval 
p-value†  
Individual Level:  
Age (scaled) 0.86 0.83 – 0.89 <0.001 
Female Sex 0.83 0.78 –0.88 <0.001 
HIV positive 0.63  0.38 - 1.03  0.067 
Education Category:      
   No school (REF) -- -- -- 
   Primary school 1.05 0.92 – 1.18 0.473 
   Secondary school 0.98 0.85 – 1.13 0.761 
   Higher than secondary  0.51 0.38 – 0.70 <0.001 
Wealth Category:      
   Poorest (REF) -- -- -- 
   Poor 0.93 0.83 – 1.04 0.189 
   Middle 0.95 0.85 – 1.06 0.330 
   Rich 0.87 0.73 – 1.02 0.088 
   Richest 0.50 0.40 – 0.61 <0.001 
Owns a Net 0.92 0.82 – 1.03 0.138 
Slept under LLIN  0.83 0.76 – 0.91 <0.001 
Net type:    
   No net (REF) -- -- -- 
   Permethrin 0.94 0.78 – 1.12 0.477 
   Alphacypermethrin  0.68 0.38 – 1.22 0.198 
   Deltamethrin 0.81 0.73 – 0.91 <0.001 
Household level:     
Net ratio*  0.85  0.76 - 0.95  0.003 
Modern Housing 0.58 0.49 – 0.69 <0.001 
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Metal Roofing  0.66 0.58 - 0.75 <0.001 
Cluster Level:  
Urban  0.70 0.37 - 0.83 <0.001 
LLIN ownership** 0.97 0.93 – 1.00 0.058 
LLIN usage** 0.98 0.92 – 1.04 0.457 
LLIN usage (deltamethrin and 
alphacypermethrin nets only)** 
0.95 0.90 - 1.00 0.040 
Education 0.91 0.79 – 1.04 0.174 
Wealth 0.87 0.83 – 0.92 <0.001 
Precipitation (scaled) 1.06 0.97 – 1.17 0.179 
Temperature (scaled) 1.32 1.23 - 1.42 <0.001 
Temperature range (scaled) 0.91 0.85 – 0.98 <0.001 
Vegetation Index (scaled)  1.18  1.09 – 1.27 <0.001 
SP†† use amongst pregnant 
women**  
0.92 0.89 - 0.96 <0.001 
Drug Resistance Prevalence**      
  Pfdhps A437G 0.88 0.85 – 0.91 <0.001 
  pfdhps K540E 0.95 0.93 – 0.98 <0.001 
  pfdhps A581G 0.89 0.85 – 0.94 <0.001 
  pfcrt K76T  0.93 0.91 – 0.96 <0.001 
† P- value of the test of the null hypothesis that the PR = 1  
†† Sulfadoxine/pyrimethamine 
* Ratio >=0.5 vs <0.5 













CHAPTER FOUR: INCREASED PATENT MALARIA IN THE DRC: GEOGRAPHIC 
AND EPIDEMIOLOGICAL CHANGES FROM 2007 TO 2013-2014 
Introduction:  
As worldwide efforts to reduce malaria transmission have stalled, there is an increasing 
need to evaluate the effects of malaria control programs87. Despite increased investment in 
malaria control, there are a number of growing threats to progress. These include increasing 
insecticide resistance to pyrethroids, an insecticide used to treat many long-lasting insecticide 
treated nets (LLINs),128 and resistance to many commonly used anti-malaria therapeutics53,103,127. 
Specifically, mutations of the Plasmodium falciparum dhps gene are associated with failure of 
sulfadoxine-pyrmethamine (SP); the drug provided to pregnant women to prevent infection 
during pregnancy4,6. Considering these threats, monitoring the effectiveness of interventions is 
critical for ensuring the success of malaria control programs.  
Understanding the effects of intervention programs is particularly important in the 
Democratic Republic of the Congo (DRC), which has the second highest malaria burden in the 
world87. With an estimated 25 million cases of malaria in 2017, the DRC is home to 12% of 
cases worldwide11,87. Additionally, multiple studies have demonstrated that parasites from the 
DRC are genetically related to parasites from both East and West Africa, indicating that the DRC 
acts as a bridge of transmission across the continent72,86. These findings, along with the large size 
and population of the country, highlight the particular importance of reducing transmission in the 
DRC.  
There is evidence that the prevalence of malaria in the DRC has remained steady or even 
increased over the past two decades. The World Health Organization (WHO) estimated that there 
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were approximately 23,620,000 total cases in 2006 and 23,378,784 in 2013, demonstrating that 
prevalence remained relatively steady between these two years11,129. However, recent WHO 
estimates also reported an increase of more than 500,000 infections in the DRC between 2016 
and 201714. Additionally, the proportion of hospitalizations due to malaria increased from 46% 
in the 2005 – 2007 period to 55% in the 2011 – 2014 period20. Similarly, a recent study found 
that the number of reported malaria cases increased between 2005 and 2014. However, the 
authors hypothesize that this is due to an increase in detection and improved diagnostics rather 
than an increase in transmission130. These findings indicate that the state of malaria over the past 
decade remains unclear. In this study, we aimed to assess changes in malaria prevalence amongst 
adults using the most recently collected nationally representative, population-based data.   
Over the past two decades, the DRC increased investment in malaria control programs. 
Two main intervention programs are LLINs and intermittent preventive therapy for pregnant 
women (IPTp)20. Indoor Residual Spraying (IRS) is limited and only performed in select areas 
by private companies; there is no national IRS program20. Both the LLIN and IPTp programs 
have been scaled up through efforts from the Ministry of Health (MoH) and multiple health 
organizations working in specific regions of the DRC131. The MoH and the World Bank began 
extensive bed-net distribution campaigns in 2007 and 200875. The President’s Malaria Initiative 
(PMI), which supports LLIN distributions and provides SP for IPTp programs, increased its 
annual budget for control programs in the DRC from approximately 7 million dollars in 2007 to 
37 million in 2010131. During this period PMI programs also included community-based malaria 
education and training for health care workers regarding IPTp delivery131. However, as the 
burden of malaria remains high within the DRC, the actual protective effects of these 
intervention programs need to be investigated.  
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 In this study, we aimed to understand differences in the spatial distribution of malaria 
between 2007 and 2013 and determine the impact of the LLIN and IPTp programs. As malaria is 
known to demonstrate high spatial heterogeneity, we sought to understand changes in prevalence 
on a sub-national scale3,16. Evaluating the effects of the intervention programs will help the MoH 
plan future intervention programs and ensure that control efforts are maximally effective.  
Methods:  
Study populations: This analysis utilized data drawn from the 2007 and 2013-2014 
Demographic Health Surveys (DHS). A full description of the DHS is provided in Chapter 
Three.  
Intervention and covariate data: Data regarding LLIN and IPTp use were drawn from the 
DHS. The DHS asks several questions regarding LLIN use; for this analysis, we determined 
LLIN use by whether the individual reported sleeping under an LLIN the previous evening. A 
previous sensitivity analysis discussed in Chapter Three demonstrated no difference between the 
choice of LLIN use measurement between the different questions132. The DHS also collected 
data regarding the LLIN brand, which we used to determine the insecticide with which the net 
was treated. Questions regarding IPTp use asked women whether they received SP during their 
most recent pregnancy and if so, how many doses. The DHS questionnaire asks all women if 
they are pregnant at the time of the survey as well as whether they have been pregnant in the 
previous five years.  
Data regarding additional covariates, such as age, wealth index, and level of education, 
were also drawn from the DHS. The DHS constructs a five-category composite wealth index 
based on a questionnaire of individual and household assets95. Additionally, we assessed anti-
malarial use amongst children under the age of 5 (the DHS does not collect these data amongst 
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all adults). We also included an urbanicity score, a composite variable based on multiple factors 
with a demonstrated relationship to urbanicity. The method for constructing this variable has 
been previously described in Chapter Three132.   
Molecular Diagnosis of Patent Infections:  The outcome for this study was patent malaria 
infection, defined as at least 100 parasites per microliter of blood. In both 2007 and 2013, we 
used quantitative Polymerase Chain Reaction (qPCR) to determine malaria infection. However, 
the qPCR assays used to detect the presence of malaria parasites differed between surveys, 
making a direct PCR comparison difficult. The 2007 assay targeted the 18S region of Plasmodia 
ribosomal DNA133, while the 2013 assay targeted the P.f. lactase dehydrogenase gene (pfldh), as 
previously described101. For the 2007 survey, DNA was extracted from blood spots using a 
QIAamp 96 DNA blood kit (Quiagen, Germantown Maryland); DNA was extracted from blood 
spots from the 2013 survey using Chelex extraction. All samples were run in duplicate. 
To determine the most appropriate method of comparison, we evaluated assay performance 
by running both assays on a subset of 160 samples from the 2013 DHS. Using the 18S assay 
(used in 2007) as the gold standard, the sensitivity of the pfldh assay (used in 2013) was only 
57%, though the specificity was 100% (Supplementary Table B1). The limit of detection 
(LOD) also differed between the assays (LOD of the 18S assay = <1 parasite/uL134; LOD of the 
pfldh assay = 10-50 parasites/uL9). We selected a threshold of 100 parasites/uL in order to 
directly compare the assays. This cutoff is also the LOD for microscopy, a commonly used 
method for diagnosing malaria. Thus, this is a clinically meaningful comparison. After applying 
the 100 parasites/uL thresholds, agreement between the assays was 97.5% (Supplementary 
Table B2). We determined sample parasite densities using standard curves from controls with 
known densities.  
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Spatial analysis: The sampling clusters used in the 2007 DHS changed for the 2013 DHS. In 
2007, 300 clusters were selected, while a set of 536 new clusters were selected in 2013 (Figure 
4.1). These changes prohibit a direct comparison of cluster-level malaria prevalence across time. 
To address this issue, we aggregated the cluster-level data to the 26 provinces of the DRC 
(Figure 4.1), incorporating the survey sampling weights.  
Within the boundaries of the 26 provinces, the DRC is further divided into 150 territories 
(Figure 4.2). To assess changes in prevalence on a smaller spatial scale, we also aggregated the 
data to the territory level. There were seven territories that did not have a DHS sampling cluster 
in 2013, and 36 with no sampling clusters in 2007. We imputed missing covariate data using 
ordinary kriging with the sp package in R135. We did not impute outcome data for the seven 
territories without prevalence data from 2013; these territories were not included in the models.   
We assessed the extent of spatial autocorrelation of the data at the province and territory-
level by estimating Moran’s I statistics. Moran’s I measures correlation in data over distance, 
ranging from -1 (perfect dispersion) to +1 (perfect correlation)136,137. We estimated Moran’s I 






Figure 4.1: Sampling locations from the 2007 (left) and 2013-2014 (right) Demographic and Health 
Surveys. A total of 300 sampling clusters were included in 2007; 536 clusters were included in 2013-
2014. Province boundaries are indicated in black.  
 
 










Figure 4.2: Map of the territories within the DRC. The 150 territories of the DRC are outlined in 
black; the 26 provinces are outlined in red.   
Analysis of IPTp:  
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To assess overall uptake of IPTp, we evaluated IPTp use amongst women who reported a 
pregnancy in the previous five years. Women were categorized as having received any IPTp, at 
least two doses of IPTp, or not receiving IPTp. To assess the relationship between IPTp use and 
patent infections, we evaluated only women who were pregnant at the time of the DHS survey 
(when the malaria testing was conducted). We assessed the proportion of pregnant women with 
patent infections who received IPTp versus those who did not receive IPTp using chi-squared 
tests. We also used Fisher’s exact tests if any category had fewer than five women. 
LLIN Modeling: As we aggregated data to the territory-level, we chose to use area-level 
models. These models assessed the relationship between territory-level LLIN use and the change 
in patent infection prevalence between 2007 and 2013. We fit both standard non-spatial 
multilevel models including a random effect for province, and models with a spatial random 
effect in order to incorporate the data’s spatial dependence. We compared model fit using the 
Deviance Information Criterion (DIC) and selected the final models based on the lowest DIC.  
We fit models with a spatial random effect using the CARBayes package in R83. The 
models had the following form: 
 
Yk = XTk 𝞫 + ɸk 
 
Here, Yk represents the difference in prevalence for each spatial unit k (each territory), X 
represents a matrix of covariates for each k and 𝞫 is a vector of regression coefficients linking 
the covariates to the response variable. Lastly, ɸ represents the spatial random effect. As these 
were area-level models, we chose a conditional autoregressive correlation structure for ɸ (further 
 50 
details provided in the Appendix B). The model was fit using Markov chain Monte Carlo and run 
with 100,000 iterations. Details regarding model priors are provided in Appendix B.  
For both sets of models, the primary exposure was the proportion of individuals reporting 
LLIN use. We assessed the effect of all LLIN use, and use of nets treated with deltamethrin or 
alphacypermethrin only. We subset to these insecticides as they were the only insecticides that 
demonstrated efficacy in previous studies2. The outcome from the models was the difference in 
territory-level prevalence between 2013 and 2007. We also fit both crude and adjusted models in 
order to account for confounders of the effect of LLIN use on malaria prevalence. All 
proportions were logit transformed.  
As a secondary analysis, we also estimated the effect of individual LLIN use and 
assessed differences in the effects between provinces. To accomplish this, we fit non-spatial 
multilevel models. These models assumed a binomial distribution with a random intercept for 
province and a random slope for LLIN use. This allowed the effect of LLIN use to vary between 
provinces. However, these models did not account for the data’s spatial dependence.  We fit the 
models using the lme4 package in R138 and determined standard errors for random effects using 
the merTools package139. The full model specification is presented in Appendix B.   
We determined confounders of the LLIN association with malaria infection based on the 
literature, biological plausibility, and constructing Directed Acyclic Graphs. Potential 
confounders of the LLIN-malaria relationship were: age, wealth index, education level, degree of 
urbanicity, community-level net use in 2007, and patent infection prevalence in 2007. As 





 A total of 8,698 individuals from 2007 and 16,126 from 2013 had available molecular 
and DHS survey data (Table 4.1). In the 2013 DHS, 44 clusters were missing GPS coordinate 
data and were excluded from the analysis. Individuals who were not considered “du jure” 
(members of the household rather than visitors) were also excluded.   
 The national prevalence of patent P.f. malaria increased from 2.4% (SE = 0.3) in 2007 to 
7.5% (SE = 0.4) in 2013. Province-level prevalence estimates ranged from 0 - 6.6% in 2007 to 
1.2 – 15.1% in 2013 (Figure 4.3). Full province-level data are available in Supplementary Table 
B3. The median age of those infected was unchanged between years, 21.5 in 2007 (IQR= 18-31) 
and 22 in 2013 (IQR = 18-31) (Supplementary Figure B1). Use of both LLINs and IPTp 
increased between surveys, though uptake was heterogeneous across the DRC (Figure 4.4). 
However, clusters with high LLIN use (>50%) also reported higher IPTp use than clusters with 
lower LLIN use (28% vs 22%, X2 = 5.776, p = 0.016). Overall use of anti-malarial drugs 
amongst children who had a fever remained steady between 2007 (29.7%) and 2013 (28.2%) 
(Supplemental Table B4). However, the types of anti-malarial drugs shifted between 2007 and 
2013, with a higher proportion of children taking Artemisinin combination therapies (ACTs) and 
quinine in 2013 as compared to 2007 (Supplemental Table B4).  
Tests of spatial autocorrelation: The results of the Moran’s I tests indicated low evidence 
of spatial autocorrelation at the province-level (I = 0.066, p = 0.175). At the territory-level, the 
test indicated moderate spatial autocorrelation (I = 0.107, p = 0.019).  
Analysis of IPTp results: Overall, the proportion of women who received IPTp during 
their most recent pregnancy increased between surveys (Table 4.1). However, uptake of IPTp 
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remains low; only 13.6% of women pregnant in the past five years received at least two doses of 
SP (three doses is recommended) (Table 4.1). 
Five-hundred and twenty women (12.2%) included in the 2007 DHS were pregnant; 1062 
women (12.7%) were pregnant in 2013. Prevalence of patent infections amongst pregnant 
women increased from 4.2% (SE = 0.8) to 12.3% (SE = 1.0) (X2 = 25.326, p <0.001). Amongst 
women who received any IPTp, the proportion of infected women was slightly lower than 
amongst women who did not receive IPTp, in both 2007 [2.1% vs. 4.5%] and 2013 [9.5% vs. 
13.1%]. (Table 4.2). The proportions of patent infections amongst women who received at least 
two doses of IPTp was slightly lower than amongst women who did not receive at least two 
doses in 2007 [0% vs. 4.4%], though the proportions were similar in 2013 [12.1% vs. 12.3%] 
(Table 4.2).  
 
 
Figure 4.3: Map of patent infection prevalence in 2007 (left) and 2013 (right). Patent infection 







Figure 4.4: The proportions of respondents reporting sleeping under a LLIN and the proportions of 
women reporting receiving IPTp during most recent pregnancy in 2007 (left) versus (2013). 
Increases in LLIN and IPTp use were heterogeneous across the DRC.  
 
 
LLIN modeling results:  The best fitting model was a multilevel model with a non-spatial 
random intercept, adjusted for several confounders (DIC = -364.00) (Table 4.3). Thus, the 
results from this model represent our primary findings; increasing LLIN use was associated with 
a reduction of only 1.7% (95% CI = -3.2%, -0.3%) in patent infection prevalence between 2007 
and 2013 (Table 4.3). We did not see a difference in the association when restricting LLIN use 
to only deltamethrin and alphacypermethrin nets (Table 4.3). Results from the spatial model 
matched those from the non-spatial models (Supplementary Table B4).  
In the secondary analysis, we found a protective effect of individual LLIN use, though 
the protection was stronger for those who used deltamethrin and alphacypermethrin nets 
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(Supplemental Table B5). The results of these models indicate that there are differences in the 
protective effect of individual net use across the country (Supplementary Figure B2), though 
these differences are attenuated when restricting to deltamethrin and alphacypermethrin net use 
only (Supplementary Figure B3). For deltamethrin and alphacypermethrin nets, the effects 
ranged from approximately OR = 0.50 (SE = 0.20) to OR = 0.83 (SE = 0.16). We found no 
individual protective effect of permethrin treated nets (Supplementary Table B6). Within each 
province, the proportion of all LLINs used that were treated with permethrin differed from under 
5% to approximately 50% (Supplementary Figure B4).  
Discussion:  
 In this study, utilizing data from the largest, most recent, and nationally-representative, 
population-based health surveys conducted in the DRC, we found a three-fold increase in the 
prevalence of patent P. falciparum infections amongst adults between 2007 and 2013. We also 
found high spatial heterogeneity of the changes in prevalence, with increases as large as 12.8%. 
Importantly, the map of changes in prevalence does not reflect the regions where health 
organizations work or where intervention programs were rolled out between 2007 and 2013131. 
These findings indicate that further investment in malaria control is needed in the DRC, 
particularly in the regions that had the highest increases. These findings support those from other 
groups that hospitalizations due to malaria increased during this same time period, and that the 
proportion of individuals testing positive for malaria increased (by RDT and microscopy)20,130. 
While the authors of the latter study suggest that this increase is due to the introduction of RDTs, 
the findings from the present study support the notion of a true increase in infections.  
Though it is possible that the prevalence of patent infections increased between 2007 and 
2013 while malaria prevalence overall dropped during this time, the data from this study support 
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the notion of a true increase in prevalence. As prevalence decreases, we expect a decrease in 
immunity to infection and thus an increase in the proportion of high-parasitmetic patent 
infections69. Thus, the increase in patent infections that we observed in this study may be a result 
of an overall decrease in prevalence. However, in this scenario, we would expect to see a shift in 
the age distribution of those infected, with patent infections occurring amongst older individuals 
in 2013 compared to 2007140. We did not observe any such change in the shape of the age 
distribution or in the median age of those infected between 2007 and 2013, which again supports 
the conclusion that prevalence increased during this time-period.  
Interestingly, we found that most children with fevers received quinine in both 2007 and 
2013, and quinine represented a larger proportion of the of anti-malarial therapeutics distributed 
between 2007 and 2013. Quinine is not a recommended treatment for malaria in the DRC; 
Artesunate/Amodiaquine has been the first line recommended treatment since 200577. While 
these data are from children, it is important to note that nearly two thirds of children with fevers 
in 2013 received a malaria drug that is not the recommended treatment.  
We found that the prevalence of patent infections increased amongst pregnant women. 
This is particularly concerning, as pregnant women are at risk for developing placental malaria, 
potentially leading to adverse birth outcomes such as premature delivery or a baby of low birth 
weight6,8. Importantly, we found that amongst women who received any IPTp, the proportion 
with patent infections was only slightly lower than the proportion amongst women who did not 
receive IPTp. However, the low number of women who received IPTp limits our ability to make 
definitive conclusions regarding the efficacy of the IPTp program.  
Despite an increase in IPTp use from 2007, overall use remains low, particularly the full 
course of three SP doses. In 2013, only 13.6% of women reported receiving at least two of the 
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three recommended doses of SP during their most recent pregnancy. This proportion is far lower 
than that of other sub-Saharan African countries; 60% of Ghanaian women and 37% of Kenyan 
women reported receiving all three doses of SP during their previous pregnancy141. In the 
neighboring country of Uganda, the proportion was 25%141. Barriers to IPTp uptake from other 
countries include drug shortages at health facilities, improper training for facility staff, and lack 
of community knowledge of IPTp programs142. The maps of IPTp uptake demonstrate 
heterogeneous uptake across the DRC, indicating that certain regions likely have better health 
infrastructure and access to health facilities. This notion is supported by the finding that areas 
with high LLIN usage also had higher IPTp usage. Additional work is needed in the DRC to 
understand the factors that are contributing to the low uptake of IPTp and determine strategies 
for increasing use.  
The results of the territory-level LLIN models indicate that increasing LLIN usage was 
associated with only a small decrease in patent infection prevalence. From these results, we 
cannot conclude that LLINs did not provide any protection, as it is difficult to determine what 
the patent infection prevalence in 2013 would have been had LLIN use remained at the 2007 
levels. However, it is important to note that despite a large increase in LLIN use between 2007 
and 2013, the prevalence of patent infections increased. These findings point to additional factors 
driving the increase in prevalence, which warrants further study. It is critical to determine 
whether LLIN use truly provides only a slight protection, or if other factors (such as insecticide 
resistance) are overwhelming the true protective effect of LLINs. The findings from the present 
study indicate that additional control measures are necessary to reduce malaria burden amongst 
adults in DRC.  
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The finding that increasing LLIN use demonstrates only a slight protective association 
with patent infections amongst adults is supported by several studies of Anopheles biting 
behavior. A study from Burkina Faso found that Anopheles mosquitoes begin biting around 
sunset, before many adults go to sleep, rendering the bed-net less useful120. More concerning is 
the finding from a study conducted in Papua New Guinea that Anopheles biting behavior shifted 
earlier in the evening after a bed-net distribution campaign121. Currently, the DRC does not have 
sufficient entomological monitoring to determine if this has occurred20; however, that adults are 
exposed to Anopheles biting for several hours before they go to sleep may help explain the 
limited protection from LLINs that we observed in this study. Thus, for adults in particular, who 
go to sleep later in the evening than children, vector control methods such as IRS may help 
reduce malaria prevalence.  
There are several strengths of this study. We utilized data from the two population-based, 
national health surveys conducted in the DRC. These surveys include data from over 24,000 
individuals. This is the first study, to our knowledge, to evaluate changes in malaria in the DRC 
amongst adults over time using nationally-representative data. Previous studies, including those 
from the Malaria Atlas Project, have focused exclusively on children or pregnant women, or 
were not nationally-representative16,130. Thus, this study adds a critical piece to the body of 
research focused on malaria in the DRC. Additionally, we utilized qPCR data, the most sensitive 
method for detecting malaria9.  
The findings from this study are subject to limitations. The first is that the intervention 
data utilized were obtained from self-reports, which is subject to recall bias. To minimize this 
bias, the DHS asks multiple questions regarding LLIN use. Our analysis of these data indicated 
no differences amongst the various questions the DHS uses to assess LLIN use. This provides 
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assurance that the recall bias is low. Additionally, as we only assessed prevalence of patent 
infections, we were unable to report changes in the overall prevalence of malaria amongst adults. 
However, as patent infections are those that are detectable by microscopy, this is a clinically 
meaningful measure for the DRC. Lastly, we utilized ecological models and thus the findings 
from the territory-level models cannot be interpreted on an individual scale.  
Conclusions:  
Patent P. falciparum infection increased three-fold amongst adults in the DRC between 
2007 and 2013-2014. Though use of LLINs and IPTp increased, uptake remains relatively low 
and further investment is needed to ensure the success of these programs. Additional factors, 
such as drug and insecticide resistance, could have contributed to the increased prevalence of 



























Table 4.1: Description of individuals included in the 2007 and 2013-2014 DHS Surveys  
 
 2007 DHS 2013-2014 DHS 
Number of adults sampled 9,275 18,275 
Number of DHS clusters 300 536 
Number of individuals with PCR data 9,218 17,934 
Number of individuals included in 
analysis  
8,698 16,126 
Age range in years  15-59 15-59  
Median Age (IQR)  27 (20-35) 28 (20-38) 
Percent Female  48 52 
% of individuals reporting sleeping 
under an LLIN  
 11.9% 54.0%  
% of pregnant women reporting 
receiving any IPTp 
15.8% 31.1% 
% of pregnant women receiving at least 
two doses of IPTp 




















Table 4.2: Proportion of women pregnant at time of the DHS with patent infections by IPTp 
status in 2007 and 2013 
 
 
Survey Year                 2007 2013-2014 
 Received  
any IPTp 
    Did not 
receive IPTp 






Total N (%) 49 (9.4) 471 (90.6)   232 (21.8) 830 (78.2)   
N with patent 
infections  
(%, SE)  
1 (2.1, 2.0) 21 (4.5, 0.1)     0.711 22 (9.5, 1.9) 109 (13.1, 
1.2) 
0.167 
 Received 2  
doses of IPTp 
Did not receive 
2 doses of IPTp 
  p-value Received 2 
doses of IPTp 
Did not receive 
2 doses of IPTp 
p-value 
Total N (%) 22 (4.4) 498 (95.6)   99 (9.3) 963 (90.7)   
N with patent 
infections  
(%, SE)  
0 (0, 0) 22 (4.4, 0.1)    0.6411 12 (12.1, 3.3) 199 (12.3, 
1.1) 
~1.000 
 Received 2  
doses of IPTp 
Received 1 
dose of SP 
 p-value Received 2  
doses of IPTp 
Received 1 
dose of SP 
p-value 
Total N (%) 22 (44.9) 27 (55.1)   99 (42.7) 133 (57.3)   
N with patent 
infections  
(%, SE)  
0 (0, 0) 1 (3.7, 3.6) ~1.000 12 (12.1, 3.3) 10 (7.5, 2.3) 0.339 

















Table 4.3: Results of territory-level multilevel models of LLIN use on change in patent 
prevalence. The exposure for each model is proportion of adults reporting using an LLIN, the 
outcome is change in territory-level prevalence between 2007 and 2013. The beta coefficients 
represent the change in patent prevalence associated with an increase in territory level net use 
  
  
Exposure  Beta 95% CI DIC Beta 95% CI DIC 
  Crude Adjusted* 
Proportion of LLIN use  
(all nets)** 
   -0.017 -0.031, 
-0.003 
-321.84 -0.017 -0.031, 
-0.003 
-364.00 





-327.11 -0.011 -0.020,  -
0.003 
-366.53 
*models are adjusted for territory-level patent prevalence in 2007, net use in 2007, average education 
level, and urbanicity score 





















CHAPTER FIVE: CONCLUSION 
Summary of Aims:   
In this dissertation, I sought to assess the current state of malaria amongst adults in the 
DRC. Despite being home to the second highest burden of disease in the world, there are few 
nationally-representative studies of malaria in the DRC. The only nationally-representative 
surveys of adults in the Congo were conducted in 2007 and 2013-14. Several studies have been 
conducted amongst children under the age of five in the DRC, describing the high national 
prevalence of infections (38.6%), areas of highest prevalence, and risk factors for infection2,9,116. 
However, no such studies have been conducted amongst adults in the DRC; understanding 
malaria epidemiology amongst adults is critical, as discussed in the Chapter Two. Thus, the 
overarching goals of this dissertation were to understand who is infected, where are people 
infected, and how effective are the interventions that the DRC has in place to reduce prevalence.  
The Aims of this dissertation were formulated to address these questions. In Aim 1, I 
evaluated the prevalence of spatial distribution of infections, as well as risk factors for infection. 
I also sought to understand whether these risk factors differed between urban areas versus rural 
areas. We found a high national prevalence, ~30%, and a high amount of spatial heterogeneity 
amongst those infected. Additionally, we identified several individual, household, and 
community-level risk factors, which will help the DRC detect people and groups more likely to 
be infected. Several risk factors demonstrated modification by urban status, indicating the need 
to tailor intervention programs to urban versus rural areas. In Aim 2, I investigated changes in 
malaria prevalence between 2007 and 2013 and assessed whether malaria control programs have 
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helped reduce malaria prevalence. Over the past two decades, the DRC scaled up investment in 
two main intervention program, LLINs and IPTp. However, no studies have specifically 
evaluated the effects of these programs amongst adults. We found that the prevalence of patent 
infections increased from 2.4% to 7.5%, though within each province, prevalence increased as 
much as 12.8%. Importantly, increasing LLIN use was not associated with lower patent 
prevalence. While LLIN use increased, a result of the many LLIN distribution campaigns over 
the past decade, only about half of adults reported sleeping under a net in 2013. Similarly, IPTp 
use was low; the MoH must invest in scale-up of IPTp to prevent infections amongst pregnant 
women. The findings from Aim 2 indicate that the state of malaria amongst adults in the DRC 
has gotten worse over the past decade, despite increased investment in control strategies.   
Conclusions:  
The findings from this dissertation highlight the dire state of malaria in the DRC and the 
need to re-evaluate current control strategies. This is highly concerning considering the many 
years of work and millions of dollars that the DRC has invested in malaria control programs20. 
Further work, discussed below, is needed to understand barriers to intervention uptake and 
ensure that all adults have access to LLINs and pregnant women to IPTp. The DRC may benefit 
from investing in additional intervention programs, many of which have been successful in other 
countries. These programs include seasonal malaria chemoprevention, intermittent preventative 
therapy for infants (IPTi), and IRS143. Introducing these programs will require an additional 
financial investment and increased infrastructure. However, the evidence from this dissertation 
indicates that such programs may be necessary.  
Interestingly, the findings from our studies do not confirm those presented by the Malaria 
Atlas Project (MAP), which indicated a steep drop in prevalence of malaria amongst children 
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between 2000 and 2017144. These differences are not surprising given the high uncertainty of the 
MAP estimates144. Though MAP utilizes sophisticated modeling techniques, the lack of 
nationally-representative studies of children in the DRC limits the ability to make inferences 
regarding national prevalence estimates over time. Between 2000 and 2017 there has only been 
one such study of children in the DRC, the 2013-2014 DHS, which included approximately 
8,000 children. In the present studies, we analyzed data from over 20,000 adults, at two time-
points. Thus, this dissertation fills a critical gap in the literature regarding malaria prevalence in 
DRC.  
Large-scale systemic factors, though not directly related to malaria control, likely 
contribute to the high burden of disease and limited progress over the past decade. The DRC 
suffers from political instability, regional violence, and widespread poverty, all of which 
undoubtedly impact the current state of malaria control145. These factors lead to low economic 
growth and inadequate health infrastructure, which limits the utility of malaria intervention 
programs66. This makes planning malaria control efforts more challenging as they all must be 
considered within the current political and economic context. Question that must be considered 
include whether it is possible for the DRC to implement a national IPTi program given the 
current state of health infrastructure and how to ensure that malaria control programs reach 
people living in conflict zones. It is not surprising that systemic factors influence malaria 
transmission. Historically, economic development and modernization both helped eliminate 
malaria in the United States146. Similarly, as discussed in this dissertation, urbanization 
contributes to large reductions in malaria prevalence worldwide57,58. The importance of such 
broader factors indicates that though malaria intervention programs are useful, large-scale 
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structural changes such as economic growth and infrastructure development are necessary for 
ensuring sustained malaria control in the DRC.   
This dissertation fills a critical gap in the literature by adding insight into the 
epidemiology of malaria amongst adults and adds to the body of work regarding malaria 
epidemiology in the DRC. The findings will hopefully aid malaria control programs, both in the 
DRC and other sub-Saharan countries. The findings and conclusions should also serve as a 
foundation for additional studies in the DRC.  
Future Directions: 
There is certainly more work that must be done to combat malaria in the DRC. 
Evaluating programmatic data from groups such as PMI and SANRU will help further our 
understanding of the effects of the intervention programs. These data were not available for these 
studies and thus I relied on self-reported data. However, future studies should aim to determine 
the impact and effectiveness of the LLIN and IPTp distribution programs, in addition to the 
effect of LLIN and IPTp use itself. While national surveys such as the DHS are critical tools for 
assessing the effects of intervention use, programmatic data will provide an additional 
perspective to help improve malaria control policies147. Quantifying the number of LLINs 
distributed within each territory and the number of doses of IPTp delivered to each health zone 
will allow the MoH to identify areas in greatest need of help.  
Further work utilizing qualitative methods will help shed light on LLIN and IPTp use 
patterns. Understanding behaviors regarding intervention use or barriers to use is necessary to 
develop strategies for increasing use. As mentioned in Chapter Four, various barriers, such as 
lack of access to health facilities and insufficient training for healthcare providers, have been 
reported in other sub-Saharan African countries. Interviews and focus groups with community 
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members, health workers, and members from PMI and SANRU will provide necessary insight 
and points of view to help elucidate what factors are hindering intervention uptake in the DRC.   
Regarding Aim 1, determining the causal effects of the identified risk factors will further 
our understanding of the mechanisms driving malaria risk. The purpose of this study was to 
identify marginal associations, not causal effects. Though marginal associations are useful for 
identifying individuals or groups at higher risk for infection, they are not necessarily useful for 
informing intervention programs or policy. However, the associations identified in this study 
present avenues for future work. Specifically, the protective association of modern housing and 
metal roofing should be further explored using causal inference methods. A protective causal 
effect would indicate that housing improvements can be used as a method for reducing malaria 
risk. Thus, the findings from Aim 1 should serve to generate questions and hypotheses for future 
studies.  
Regarding Aim 2, future studies should aim to further assess factor contributing to 
changes in malaria prevalence such as environmental changes. In Aim 2, I assessed LLIN and 
IPTp use only; however, changes in temperature or rainfall between 2007 and 2013 have also 
likely played a role in the differences in prevalence that we observed. These factors are known to 
be associated with malaria risk and should be explored in future studies3. As the effects of 
climate change become more and more evident, it is critical to understand the role of these 
changes on malaria risk in the DRC. Mosquito breeding seasons may shift or last longer, 
affecting the seasonality of malaria risk, or increasing temperatures may cause reduced breeding 
and thus reduce risk in certain areas148,149. Understanding the role of these changes in the DRC 
may shed light on which intervention programs are likely to be more effective (i.e.: 
implementing IRS or introducing seasonal chemoprevention programs). The findings from the 
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Aim 2 indicate that there remain unstudied factors that lead to an increase in the prevalence of 
patent infections amongst adults, despite increased LLIN use. Changing climate may be one of 
these factors and should be further explored.  
 Overall, this dissertation serves to underscore the importance of studying malaria 
amongst individuals of all ages and not only focusing on children under the age of five. 
Including all age groups in future DHS and Malaria Indicator Cluster Surveys (MICS) in the 
DRC, and specifically including malaria testing, will provide critical data to improve control 
efforts. Consistent, comparable data are necessary for monitoring the progress of malaria control 
programs in the DRC. While most deaths due to malaria occur amongst children, the findings 
from this dissertation highlight the high burden amongst adults. A currently on-going MICS in 
the DRC again only includes children and thus we will not have updated data for adults. While 
including all age groups is more operationally challenging than focusing only on children, it will 




















APPENDIX A: CHAPTER THREE SUPPLEMENTARY MATERIALS 
Modern Housing variable construction: We constructed a composite “modern housing” variable 
using data from the roof, wall, and floor material variables reported in the DHS. The definition 
of modern housing was based off those used by Tusting et al96. Modern roofing materials 
included: metal, zinc/cement, tiles/slate, or cement. Modern wall material included: cement, 
stone, bricks, or covered adobe. Modern floor materials included: vinyl, asphalt, ceramic tiles, 
cement, or carpet. Only houses with a modern roof, walls, and floor materials were considered 
“modern housing”.  
PrevMap analysis: We estimated cluster-level drug resistance allele frequencies using the 
PrevMap package in R105. We fit a model in order to generate cluster-level SNP prevalence 
estimates at all sampled DHS clusters from the 1,065 children with available data. Each 
resistance mutation was analyzed individually. We first determined raw cluster-level SNP 
frequencies and then transformed the proportions using a logit transformation. We fit linear a 
geospatial model of the following form:  
 
𝑦𝑖	 = 	𝑆(𝑥𝑖) 	+ 	𝑍𝑖 
 
In this model, 𝑦𝑖 is equal to the transformed allele frequency for each cluster and 𝑆(𝑥𝑖) 
represents an isotropic Gaussian Process with a variance of 𝝈2 and a Matern correlation 
function105. 𝑍𝑖	represents a Gaussian error term105. Model parameters were estimated using 
maximum likelihood and models were run using 10,000 simulations to generate spatially smooth 
frequency estimates. After fitting the model, we extracted the frequency estimate for each DHS 
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cluster included in the analysis. To minimize bias, we averaged the estimated values for all 
geopoints within 15km square of the DHS cluster geopoint.  
We used the same model framework to generate spatially smoothed P. falciparum 
prevalence estimates (Figure 3). Using this model, we also determined the estimate error for all 
points (Supplementary Figure A1).  
Bed-net use sensitivity analysis: We evaluated four different methods for determining 
bed-net usage based on the questions asked in the DHS questionnaire. The first (M1) asked if the 
individual slept under an “ever treated” net the previous night. The second (M2) asked if the 
individual slept under a “long lasting insecticide treated net”. For the third method (M3), we 
constructed a “new net” variable based on whether the individual had obtained the net, or re-
treated it with insecticide, within the previous 3 years96. Lastly (M4), the DHS asks, “the type of 
mosquito bed-net person slept under”, with options of no net, an untreated net, or a treated net. 
We compared the estimated prevalence ratio of those who used nets versus those who did not 
based on each method’s definition of net use. The results (Figure A2) demonstrate no substantial 
differences in the effect of net use between the four methods. The variable used in M1 was used 











































Supplementary Figure A1: Standard error map for smoothed P. falciparum PCR prevalence estimates 










































Supplementary Figure A2: Results of sensitivity analysis evaluating different methods for measuring 
and coding bed-net usage. Each model compared the prevalence of PCR detectable P. falciparum 


























Supplementary Table A1: Province level P. falciparum prevalence estimates measured by PCR.  
 
Province name Prevalence % (SE) 
Kinshasa 18.6 (2.3) 
Kwango 21.4 (3.7) 
Kwilu 25.8 (5.0) 
Mai-Ndombe 43.9 (4.7) 
Kongo Central 40.5 (3.8) 
Equateur 22.4 (2.7) 
Mongala 26.3 (2.9) 
Nord-Ubangi 48.9 (5.0) 
Sud-Ubangi 31.3 (5.3) 
Tshuapa 33.7 (4.4) 
Kasai 44.5 (7.3) 
Kasai-Central 43.5 (4.0) 
Kasai-Oriental 35.9 (4.3) 
Lomami 52.5 (3.1) 
Sankuru 27.2 (3.3) 
Haut-Katanga 22.5 (3.4) 
Haut-Lomami 41.0 (5.2) 
Lualaba 38.6 (9.6) 
Tanganyka 54.3 (5.1) 
Maniema 45.5 (5.7) 
Nord-Kivu 6.7 (1.6) 
Bas-Uele 58.3 (6.4) 
Haut-Uele 42.7 (3.6) 
Ituri 33.9 (4.1) 
Tshopo 29.6 (4.9) 
Sud-Kivu 16.4 (3.2) 
 73 
Supplementary Table A2: Descriptive statistics of individuals with missing GPS data. Values are 
unweighted as sampling weights are not assigned to individuals missing location data. 
 PCR positive PCR negative 
Total (unweighted) 607 795 
Individual-level   
Age  27 (20 - 36)  30 (22 - 39) 
Female (%) 313 (51.6%) 412 (51.8) 
HIV positive (%) 8 (1.3) 9 (1.1) 
Education     
   No School 78 (12.9) 131 (16.5) 
   Primary 262 (43.2) 319 (40.1) 
   Secondary 259 (42.7) 337 (42.4) 
   Higher than secondary 8 (1.3) 8 (1.0) 
Owns a bed-net 443 (73.0) 603 (75.6) 
Slept under a bed-net 325 (53.4) 459 (57.7) 
Wealth (%)     
   Poorest 197 (32.5)       270 (34.0) 
   Poor 164 (27.0) 200 (25.2) 
   Middle 159 (26.2) 199 (25.0) 
   Rich 79 (13.0) 112 (14.1) 
   Richest 8 (1.3) 14 (1.8) 
Household-level     
Average number of bed-nets per person (SE) 0.27 (0.01) 0.27 (0.01)  
Modern Housing (%) 8 (1.3) 11 (1.4) 
Metal Roofing (%) 41 (6.8) 82 (10.3)  
Cluster-level   
Median Age (IQR) 29 (27- 30.5) 28 (26 – 30.5) 
Median Wealth (IQR) 2 (2-3) 2 (2-3) 
Median Education (IQR) 2 (2-3) 2 (2-3) 
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Supplementary Table A3: Associations between identified risk factors and P. falciparum 











Bed-net use (all brands) Rural 0.79 0.71 – 0.89 <0.001 0.442 





Rural 0.75 0.66- 0.85 <0.001 0.077 
Urban 0.94 0.77- 1.14 0.523  
Female Sex Rural 0.83 0.77 – 0.90 <0.001 0.909 
  Urban 0.84 0.75– 0.94 0.002  
Age (scaled) Rural 0.86 0.83 – 0.90 <0.001 0.537 
  Urban 0.84 0.78– 0.90 <0.001  
Modern Housing Rural 0.98 0.71 – 1.34 0.876 0.035 
  Urban 0.60 0.46 – 0.79 <0.001  
Metal Roofing  Rural 0.85 0.69– 1.03 0.099 0.002 
  Urban 0.53 0.43- 0.66  <0.001  
Wealth Rural 0.95 0.90– 1.01 0.106 <0.001 
  Urban 0.72 0.65– 0.80 <0.001  
Education Rural 1.03 0.96 – 1.11 0.435 <0.001 
  Urban 0.80 0.71– 0.89 <0.001  
Net Ratio >0.5 Rural 0.82 0.72 - 0.93 0.002 0.521 
  Urban 0.90  0.72- 1.12 0.351  
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Cluster-level:          
Deltamethrin or 
alphacypermethrin net use* 
Rural 0.93 0.89 – 0.97 0.002 0.040 
Urban 1.07 0.94– 1.21 0.299  
SP† use  Rural 0.96 0.94- 0.97 <0.001 0.458 
  Urban 1.00 0.87 - 1.15 0.953  
A437G* Rural 0.90 0.85 – 0.95 <0.001 0.599 
  Urban 0.92 0.85 – 0.99 0.032  
K540E* Rural 0.96 0.92 – 0.99 0.009 0.180 
  Urban 0.92 0.87 – 0.97 0.002  
A581G* Rural 0.85 0.78 – 0.92 0.001 0.507 
  Urban 0.80 0.67– 0.94 0.008  
CRT K76T* Rural 0.95 0.92 - 0.98 <0.001 0.649 
  Urban 0.93 0.87 - 0.99 0.029  
† Sulfadoxine/pyrimethamine 












Supplementary Table A4: Comparison of the association between individual LLIN use vs no LLIN† 
use and malaria prevalence between adults and children in the 2013-2014 Demographic and Health 
Survey. Data from children has been previously published2,9.  
Population Prevalence Ratio      95% Confidence 
Interval 
Children 0.82 0.72 – 0.91 
Adults 0.83 0.76 – 0.91 





















APPENDIX B: CHAPTER FOUR SUPPLEMENTARY MATERIALS 
Prior distributions for spatial models:We adopted the following priors for the spatial models. 
For beta coefficients, we adopted standard normal priors. For the phi spatial parameter we used a 




Here, wki represents an indicator for whether the area is a neighbor or area k. Thus, the spatial 
parameter is weighted according to the area-level neighbor matrix. Rho is the spatial 
autocorrelation parameter and can vary from 0, indicating no spatial autocorrelation, to 1, 
indicating strong spatial autocorrelation. We chose to not specify rho but rather model the 
parameter itself and provide a uniform prior(0,1). For the tau variance parameter we assigned an 
inverse-gamma prior IG(2,1), as has been adopted previously for spatial models of malaria3.   
Multilevel model specification: We used multi-level modeling to estimate the effect of 
individual LLIN use within each province. The model was of the following form:  
 
𝑃𝑟(𝑌ℎ𝑖) 	= 𝞫0	 + 𝞫(𝐿𝐿𝐼𝑁	𝑢𝑠𝑒) 	+ 	𝞫𝑋ℎ𝑖	 + 	𝑢0ℎ	 + 	𝑢1(𝐿𝐿𝐼𝑁	𝑢𝑠𝑒) 	+ 	𝑒ℎ𝑖		 
 
𝜇;<~	𝑁(0, 𝜎@;A ) 
𝜇B<~	𝑁(0, 𝜎@BA ) 
𝑒<C	~	𝑁(0, 𝑒;A) 
 
In this model, 𝑌is a binomial indicator for whether the individual had a patent infection. 
𝐵(𝐿𝐿𝐼𝑁	𝑢𝑠𝑒) is a fixed effect for LLIN use and 𝐵𝑋ℎ𝑖 is a vector of covariates. 𝑢0ℎ represents a 
random intercept for each province, and 𝑢1(𝐿𝐿𝐼𝑁	𝑢𝑠𝑒) represents a random slope for LLIN use. 
𝑒ℎ𝑖 represents random error for each individual.  
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Supplementary Figure B1.  Age distributions of patent infections in 2007 (A), 2013 (B) and the 
prorportion of total infections in each age group between 2007 and 2013 (C). We do not see a large shift 
in the age distribution over time. The median age of infection in was 21.5 (IQR = 18 - 31) in 2007 and 22 















Supplementary Figure B2: Odds ratios (left) comparing effect individual-level net use versus no 
LLIN use on odds of malaria infection. The model is adjusted for province-level net use in 2007, 
province-level patent P.f. prevalence in 2007, and cluster-level urban score. Effect standard errors are 























Supplementary Figure B3: Odds ratios (left) comparing the effect of individual-level deltamethrin 
and alphacypermethrin net use versus no LLIN use on odds malaria infection. The model is adjusted 
for province-level net use in 2007, province-level patent P.f. prevalence in 2007, and cluster-level urban 







































































Supplementary Table B1: Comparison of 161 samples included in the comparison of the 18S 
and pfldh PCR assays. The initial PCR assays had 81% agreement between the assays (i.e.: 81% 
of PCR calls were the same between the two assays).  
 
 PCR positive by 
18S 
Negative by 18S 
PCR positive by pfldh 40 0 








































Supplementary Table B2. Comparison of 161 samples included in the comparison of the 18S 
and pfldh PCR assays using the 100 parasites/uL of blood cutoff to define patent infections. 
Using this cutoff, there was 97% agreement between the assays in determining patent infections.   
 
 Patent cases 
by 18S 
Negative by 18S 
Patent cases by pfldh 8 3 








































Supplementary Table B3: Prevalence of patent infections for each province in 2007 and 
2013  
 




Kinshasa 1.8 (0.5) 4.7 (0.8) 
Kwango 3.5 (1.2) 4.3 (1.5) 
Kwilu 1.6 (0.6) 5.2 (1.9) 
Mai-Ndombe 2.0 (0.9) 10.8 (1.8) 
Kongo Central  1.2 (0.5) 11.2 (2.0) 
Equateur 6.6 (1.8) 5.7 (1.0) 
Mongala 0.9 (1.0) 6.5 (1.6) 
Nord-Ubangi 0.0 (0.0) 10.3 (1.9) 
Sud-Ubangi 1.9 (0.7) 7.5 (2.7) 
Tshuapa 5.6 (0.3) 9.6 (1.8) 
Kasai 1.6 (0.6) 14.4 (3.5) 
Kasai-Central 2.6 (0.8) 12.2 (1.5) 
Kasai-Oriental 1.5 (0.6) 7.3 (1.5) 
Lomami 3.3 (1.3) 15.1 (0.9) 
Sankuru 4.1 (2.3) 5.8 (1.3) 
Haut-Kantanga 1.1 (0.6) 4.6 (1.4) 
Haut-Lomami 1.5 (0.9) 10.6 (2.2) 
Lualaba 2.1 (1.8) 9.5 (3.9) 
Tanganyka 2.8 (1.2) 11.8 (2.4) 
Maniema 2.0 (1.2) 11.5 (3.2) 
Nord-Kivu 1.1 (0.5) 1.2 (0.6) 
Bas-Uele 2.7 (0.5) 11.4 (4.0) 
Haut-Uele 5.7 (2.0) 11.0 (2.0) 
Ituri 3.1 (1.8) 9.5 (2.9) 
Tshopo 4.0 (2.3) 11.2 (4.2) 
















Supplemental Table B4: Description of anti-malarial drug use amongst children under the 
age of 5 that reported having a fever in the two weeks prior to the survey.  
 
 2007 2013 
Total Febrile  1,856 3,544 
Received any anti-malarial (%):  552 (29.7) 998 (28.2)  
Anti-malarial received (%):    
Fansidar 46 (8.3) 63 (6.3) 
Chloroquine 119 (21.6) 22 (2.2) 
Amodiaquine 86 (15.6) 79 (7.9) 
ACTs* 20 (3.6) 158 (15.8) 
Quinine 281 (51.1) 676 (67.7) 


































Supplementary Table B5: Results of conditional autoregressive spatial territory-level 
models assessing effect LLIN use on change in patent prevalence. 
 
  
Exposure  Beta 95% CI  DIC Beta 95% CI  DIC 
 Crude  Adjusted*   




-316.15 -0.021 -0.036, 
-0.005 
-325.99 









*models are adjusted for territory-level patent prevalence in 2007, net use in 2007, average 
education level, and urbanicity score 




























Supplementary Table B6: Effect of LLIN use (individual and cluster-level) on individual 
odds of patent infection. The outcome for these models is individual odds of patent infection 
amongst individuals in 2013.  
 
Exposure  Beta OR 95% CI*  Beta OR 95% CI*  
 Crude Adjusted* 
All LLIN insecticides:        
Individual LLIN use -0.292 0.751 0.656 – 0.851 -0.290 0.748 0.656 - 0.853 
Cluster-level LLIN 
use  
-0.065 0.937 0.879 – 0.989 -0.068 0.934 0.882 – 0.990  
Deltamethrin and Alphacypermethrin nets only:  
Individual LLIN use  -0.385 0.681 0.593 - 0.780 -0.391 0.677 0.590 - 0.776 
Cluster-level LLIN 
use  
-0.117 0.890 0.848 - 0.934 -0.116 0.891 0.849 - 0.934 
Permethrin nets only:  
Individual LLIN use  0.052 1.053 0.821 - 1.351  0.049 1.050 0.819 - 1.347 
Cluster-level LLIN 
use 
 0.107 1.113 0.757 - 1.639  0.124 1.136 0.769 - 1.665 
*adjusted for province-level 2007 patent infection prevalence, 2007 province-level of net use, 

























APPENDIX C: COMPARISON OF PREVALENCE ESTIMATES AMONGST ADULTS 
VERSUS CHILDREN IN THE 2013-2014 DHS. 
We examined the relationship between the cluster-level prevalence amongst adults versus the 
prevalence amongst children in the 2013-2014 DHS. The correlation is 0.63 (Supplementary 
Figure C1). In most clusters (202/489) clusters, prevalence was approximately equal between 
groups (i.e.: within prevalence estimates amongst adults and children were within 10% of each 
other). In 169 clusters, prevalence was more than 10% higher amongst children than amongst 
adults. One-hundred and seventeen clusters had a prevalence amongst adults that was more than 
10% higher than amongst children. The largest outliers may be due to low sample sizes amongst 
children in some clusters. When restricting to only clusters with at least 10 adults and 10 children 
(394 clusters), the correlation is 0.66 (Supplementary Figure C2). There does not appear to be 
any spatial pattern to the clusters with high prevalence amongst adults, defined as prevalence 
amongst adults 25% or higher than prevalence amongst children (Supplementary Figure C3). 
Clusters with higher prevalence amongst adults should be explored further.  
At the province level, the correlation between adult’s and kid’s prevalence is 0.91. In one 
province, Kasai, the prevalence amongst adults is 10% higher than amongst kids 
(Supplementary Figure C4). In six provinces, the prevalence amongst children was more than 
10% higher than that amongst adults.  
 It must be noted that fundamental differences in assay performance between kids and 

































































Supplementary Figure C2: Cluster-level prevalence estimates between kids (y-axis) and adults 





















Supplementary Figure C3: Map of outlier clusters (the adult prevalence is more than 25% 
higher than the prevalence amongst children) highlighted in orange. This map displays only 















Supplementary Figure C4: Prevalence differences between children and adults. Positive 
proportions represent provinces where prevalence is higher amongst children, negative 
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